| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | glutamate receptor activity | 6.15e-07 | 27 | 236 | 6 | GO:0008066 | |
| GeneOntologyMolecularFunction | G protein-coupled glutamate receptor activity | 2.29e-06 | 9 | 236 | 4 | GO:0098988 | |
| GeneOntologyMolecularFunction | adenylate cyclase inhibiting G protein-coupled glutamate receptor activity | 2.29e-06 | 9 | 236 | 4 | GO:0001640 | |
| GeneOntologyMolecularFunction | group III metabotropic glutamate receptor activity | 6.46e-06 | 4 | 236 | 3 | GO:0001642 | |
| GeneOntologyMolecularFunction | biotin binding | 3.18e-05 | 6 | 236 | 3 | GO:0009374 | |
| GeneOntologyBiologicalProcess | actin cytoskeleton organization | MYO6 SPTBN1 PTK2B MYO3A HRAS HRG PLEC KIT CAP2 KRAS PPM1E MYOM3 TRIOBP PSTPIP1 ARHGAP35 CIT CDC42BPB ARHGEF10L PFN4 CD47 FZD10 TRPV4 MYOM2 PALLD EPB41L1 MYBPC1 | 1.90e-06 | 803 | 236 | 26 | GO:0030036 |
| GeneOntologyBiologicalProcess | adenylate cyclase-inhibiting G protein-coupled glutamate receptor signaling pathway | 2.01e-06 | 9 | 236 | 4 | GO:0007196 | |
| GeneOntologyBiologicalProcess | supramolecular fiber organization | KRT26 MYO6 USP9X SPTBN1 PTK2B KRT39 YWHAQ PLEC KRT25 CAP2 WDR72 KRT34 KRT35 KRT28 PPM1E MYOM3 TRIOBP PSTPIP1 ARHGAP35 CIT EMILIN1 ARHGEF10L PFN4 CD47 TRPV4 MYOM2 MYBPC1 NIN | 5.21e-06 | 957 | 236 | 28 | GO:0097435 |
| GeneOntologyBiologicalProcess | actin filament-based process | MYO6 SPTBN1 PTK2B MYO3A HRAS HRG PLEC KIT CAP2 KRAS PPM1E MYOM3 TRIOBP PSTPIP1 ARHGAP35 CIT CDC42BPB ARHGEF10L PFN4 CD47 FZD10 TRPV4 MYOM2 RNF207 PALLD EPB41L1 MYBPC1 | 6.28e-06 | 912 | 236 | 27 | GO:0030029 |
| GeneOntologyBiologicalProcess | inner ear receptor cell differentiation | 1.46e-05 | 96 | 236 | 8 | GO:0060113 | |
| GeneOntologyBiologicalProcess | intermediate filament cytoskeleton organization | 1.82e-05 | 99 | 236 | 8 | GO:0045104 | |
| GeneOntologyBiologicalProcess | intermediate filament-based process | 1.96e-05 | 100 | 236 | 8 | GO:0045103 | |
| GeneOntologyBiologicalProcess | inner ear receptor cell development | 2.01e-05 | 73 | 236 | 7 | GO:0060119 | |
| GeneOntologyBiologicalProcess | intermediate filament organization | 2.41e-05 | 75 | 236 | 7 | GO:0045109 | |
| GeneOntologyBiologicalProcess | mechanoreceptor differentiation | 2.61e-05 | 104 | 236 | 8 | GO:0042490 | |
| GeneOntologyBiologicalProcess | neuron development | KIFBP HLA-A MYO6 USP9X GRXCR1 ATP8B1 ADGRV1 DSCAML1 PTK2B MYO3A PTPRD TRPV2 LRRC7 PLXNA1 PLXNB3 DPYSL2 SLC4A7 LAMA3 TRIOBP LAMA5 SPG11 ARHGAP35 GRM7 CIT WDPCP BTBD3 IL1RAPL1 FRY IFRD1 ARHGEF40 KNDC1 TRPV4 TBC1D23 PALLD NIN | 2.65e-05 | 1463 | 236 | 35 | GO:0048666 |
| GeneOntologyBiologicalProcess | G protein-coupled glutamate receptor signaling pathway | 2.73e-05 | 16 | 236 | 4 | GO:0007216 | |
| GeneOntologyBiologicalProcess | neuron projection development | KIFBP HLA-A MYO6 USP9X GRXCR1 ADGRV1 DSCAML1 PTK2B MYO3A PTPRD TRPV2 LRRC7 PLXNA1 PLXNB3 DPYSL2 LAMA3 TRIOBP LAMA5 SPG11 ARHGAP35 GRM7 CIT BTBD3 IL1RAPL1 FRY IFRD1 ARHGEF40 KNDC1 TRPV4 TBC1D23 PALLD NIN | 2.82e-05 | 1285 | 236 | 32 | GO:0031175 |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | KIFBP USP9X DSCAML1 MYO3A PTPRD TRPV2 PLXNA1 PLXNB3 LAMA3 TRIOBP LAMA5 SPG11 ARHGAP35 CIT WDPCP BTBD3 IL1RAPL1 IFRD1 ARHGEF40 KNDC1 PALLD NIN | 5.24e-05 | 748 | 236 | 22 | GO:0048667 |
| GeneOntologyBiologicalProcess | glutamate receptor signaling pathway | 5.72e-05 | 59 | 236 | 6 | GO:0007215 | |
| GeneOntologyBiologicalProcess | epidermis development | TRPC4AP MYO6 ABCA12 GRXCR1 TMPRSS11F MYO3A PLEC KRT25 SLC4A7 KRT34 KRT28 LAMA3 TRIOBP LAMA5 WDPCP PALLD | 8.79e-05 | 461 | 236 | 16 | GO:0008544 |
| GeneOntologyBiologicalProcess | sensory perception of mechanical stimulus | MYO6 GRXCR1 ATP8B1 ADGRV1 MYO3A KIT SLC4A7 TRIOBP GRM7 GRM8 PKHD1L1 | 9.86e-05 | 238 | 236 | 11 | GO:0050954 |
| GeneOntologyBiologicalProcess | sensory perception of sound | MYO6 GRXCR1 ATP8B1 ADGRV1 MYO3A KIT SLC4A7 TRIOBP GRM7 PKHD1L1 | 9.87e-05 | 198 | 236 | 10 | GO:0007605 |
| GeneOntologyBiologicalProcess | regulation of plasma membrane bounded cell projection organization | HLA-A ATP8B1 PTK2B MYO3A PTPRD HRAS TRPV2 HRG LRRC7 KIT PLXNA1 PLXNB3 DPYSL2 TBC1D30 ARHGAP35 CIT WDPCP IL1RAPL1 IFRD1 KNDC1 TRPV4 PLCE1 NIN | 1.15e-04 | 846 | 236 | 23 | GO:0120035 |
| GeneOntologyBiologicalProcess | inner ear auditory receptor cell differentiation | 1.17e-04 | 67 | 236 | 6 | GO:0042491 | |
| GeneOntologyBiologicalProcess | regulation of cell projection organization | HLA-A ATP8B1 PTK2B MYO3A PTPRD HRAS TRPV2 HRG LRRC7 KIT PLXNA1 PLXNB3 DPYSL2 TBC1D30 ARHGAP35 CIT WDPCP IL1RAPL1 IFRD1 KNDC1 TRPV4 PLCE1 NIN | 1.54e-04 | 863 | 236 | 23 | GO:0031344 |
| GeneOntologyBiologicalProcess | regulation of cellular component biogenesis | ABHD17A USP9X SPTBN1 ATP8B1 PTK2B MYO3A PTPRA PTPRD HRAS HRG YWHAQ KIT PLXNB3 TBC1D30 PPM1E TRIOBP ARHGAP35 EMILIN1 WDPCP ARHGEF10L IL1RAPL1 PFN4 TRIM9 CD47 HAS3 SMCR8 PLCE1 SORL1 | 2.36e-04 | 1189 | 236 | 28 | GO:0044087 |
| GeneOntologyBiologicalProcess | hair cell differentiation | 2.72e-04 | 78 | 236 | 6 | GO:0035315 | |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection assembly | USP9X ATP8B1 DNALI1 MYO3A HRAS HRG KIT PLXNB3 TBC1D30 LAMA5 OCRL ODAD2 ARHGAP35 WDPCP PFN4 CFAP61 HYDIN PCNT PLCE1 | 2.72e-04 | 670 | 236 | 19 | GO:0120031 |
| GeneOntologyCellularComponent | stereocilium | 1.27e-05 | 69 | 236 | 7 | GO:0032420 | |
| GeneOntologyCellularComponent | actin-based cell projection | MYO6 GRXCR1 ATP8B1 ADGRV1 DNALI1 MYO3A LRRC7 SLC4A7 TRIOBP CUBN PKHD1L1 TRPV4 PALLD | 1.78e-05 | 278 | 236 | 13 | GO:0098858 |
| GeneOntologyCellularComponent | stereocilium bundle | 3.11e-05 | 79 | 236 | 7 | GO:0032421 | |
| GeneOntologyCellularComponent | cluster of actin-based cell projections | MYO6 GRXCR1 ATP8B1 ADGRV1 MYO3A PLEC RALGDS SLC4A7 TRIOBP CUBN PKHD1L1 | 4.89e-05 | 223 | 236 | 11 | GO:0098862 |
| GeneOntologyCellularComponent | cell-substrate junction | DCAF6 ERBIN PTK2B PTPRA BSG MRC2 LMLN YWHAQ PLEC KRAS RRAS2 LAMA3 TRIOBP TRPV4 PALLD | 1.65e-04 | 443 | 236 | 15 | GO:0030055 |
| GeneOntologyCellularComponent | hemidesmosome | 2.19e-04 | 11 | 236 | 3 | GO:0030056 | |
| GeneOntologyCellularComponent | M band | 3.92e-04 | 31 | 236 | 4 | GO:0031430 | |
| GeneOntologyCellularComponent | axon | MYO6 USP9X SPTBN1 HAPLN2 DBH LMTK3 DSCAML1 PTK2B TRPV2 LRRC7 PLEC FBXW11 DPYSL2 SLC4A8 SPG11 GRM3 GRM7 IL1RAPL1 TRPV4 PALLD UNC80 NIN | 5.09e-04 | 891 | 236 | 22 | GO:0030424 |
| GeneOntologyCellularComponent | laminin-5 complex | 7.50e-04 | 4 | 236 | 2 | GO:0005610 | |
| GeneOntologyCellularComponent | supramolecular fiber | KRT26 MYO6 SPTBN1 RYR1 KRT39 MYO3A YWHAQ PLEC KRT25 FBXW11 DPYSL2 DNAH10 KRT34 KRT35 KRT28 MYOM3 DNAJB4 PSTPIP1 KLHL22 DNAH12 TRPV4 MYOM2 PALLD MYBPC1 PCNT NIN | 8.65e-04 | 1179 | 236 | 26 | GO:0099512 |
| GeneOntologyCellularComponent | supramolecular polymer | KRT26 MYO6 SPTBN1 RYR1 KRT39 MYO3A YWHAQ PLEC KRT25 FBXW11 DPYSL2 DNAH10 KRT34 KRT35 KRT28 MYOM3 DNAJB4 PSTPIP1 KLHL22 DNAH12 TRPV4 MYOM2 PALLD MYBPC1 PCNT NIN | 9.54e-04 | 1187 | 236 | 26 | GO:0099081 |
| HumanPheno | Linear nevus sebaceous | 5.16e-06 | 3 | 89 | 3 | HP:0010817 | |
| Domain | GPCR_3_mtglu_rcpt | 1.64e-06 | 8 | 235 | 4 | IPR000162 | |
| Domain | NCD3G | 1.60e-05 | 13 | 235 | 4 | PF07562 | |
| Domain | GPCR_3_9-Cys_dom | 1.60e-05 | 13 | 235 | 4 | IPR011500 | |
| Domain | Keratin_I | 1.76e-05 | 44 | 235 | 6 | IPR002957 | |
| Domain | GPCR_3_CS | 2.21e-05 | 14 | 235 | 4 | IPR017979 | |
| Domain | - | IL12RB1 HLA-A HAPLN2 DSCAML1 PTPRD BSG KIT PLXNA1 PLXNB3 MYOM3 PKHD1L1 IL1RAPL1 CD1C TRIM9 BTNL2 CD47 CD300LG MYOM2 EXOC2 PALLD MYBPC1 SORL1 | 3.53e-05 | 663 | 235 | 22 | 2.60.40.10 |
| Domain | Ig-like_fold | IL12RB1 HLA-A HAPLN2 DSCAML1 PTPRD BSG KIT PLXNA1 PLXNB3 MYOM3 PKHD1L1 IL1RAPL1 CD1C TRIM9 BTNL2 CD47 CD300LG MYOM2 EXOC2 PALLD MYBPC1 SORL1 | 8.90e-05 | 706 | 235 | 22 | IPR013783 |
| Domain | ANF_lig-bd_rcpt | 9.48e-05 | 37 | 235 | 5 | IPR001828 | |
| Domain | ANF_receptor | 9.48e-05 | 37 | 235 | 5 | PF01094 | |
| Domain | PH_dom-like | SPTBN1 PTK2B PTPN3 OSBPL7 VEPH1 TRIOBP CIT WDFY4 CDC42BPB ARHGEF10L ARHGEF40 PLEKHO2 LRBA PLCH1 EPB41L1 PLCE1 | 1.04e-04 | 426 | 235 | 16 | IPR011993 |
| Domain | ARM-type_fold | TRPC4AP USP9X PSME4 AP1G2 PDS5A RIPOR1 HECTD1 VEPH1 ODAD2 WDFY4 IFRD1 PPP2R5E LRBA XPO7 | 1.06e-04 | 339 | 235 | 14 | IPR016024 |
| Domain | - | USP9X PSME4 AP1G2 PDS5A RIPOR1 HECTD1 ODAD2 WDFY4 IFRD1 PPP2R5E LRBA | 1.22e-04 | 222 | 235 | 11 | 1.25.10.10 |
| Domain | Peripla_BP_I | 1.23e-04 | 39 | 235 | 5 | IPR028082 | |
| Domain | GPCR_3 | 1.24e-04 | 21 | 235 | 4 | IPR000337 | |
| Domain | 7tm_3 | 1.50e-04 | 22 | 235 | 4 | PF00003 | |
| Domain | G_PROTEIN_RECEP_F3_2 | 1.50e-04 | 22 | 235 | 4 | PS00980 | |
| Domain | G_PROTEIN_RECEP_F3_3 | 1.50e-04 | 22 | 235 | 4 | PS00981 | |
| Domain | G_PROTEIN_RECEP_F3_1 | 1.50e-04 | 22 | 235 | 4 | PS00979 | |
| Domain | G_PROTEIN_RECEP_F3_4 | 1.50e-04 | 22 | 235 | 4 | PS50259 | |
| Domain | GPCR_3_C | 1.50e-04 | 22 | 235 | 4 | IPR017978 | |
| Domain | ARM-like | USP9X PSME4 AP1G2 PDS5A RIPOR1 HECTD1 ODAD2 WDFY4 IFRD1 PPP2R5E LRBA XPO7 | 1.68e-04 | 270 | 235 | 12 | IPR011989 |
| Domain | IF | 2.91e-04 | 72 | 235 | 6 | PS00226 | |
| Domain | Filament | 3.14e-04 | 73 | 235 | 6 | PF00038 | |
| Domain | IF | 3.90e-04 | 76 | 235 | 6 | IPR001664 | |
| Domain | GSKIP_dom | 4.69e-04 | 3 | 235 | 2 | IPR023231 | |
| Domain | TIG | 5.89e-04 | 31 | 235 | 4 | PF01833 | |
| Domain | CNH | 6.46e-04 | 14 | 235 | 3 | SM00036 | |
| Domain | IPT | 6.66e-04 | 32 | 235 | 4 | IPR002909 | |
| Domain | CNH | 8.00e-04 | 15 | 235 | 3 | PF00780 | |
| Domain | CNH | 8.00e-04 | 15 | 235 | 3 | PS50219 | |
| Domain | CNH_dom | 8.00e-04 | 15 | 235 | 3 | IPR001180 | |
| Domain | TRPV1-4_channel | 9.30e-04 | 4 | 235 | 2 | IPR008347 | |
| Domain | RAS | 9.42e-04 | 35 | 235 | 4 | PS51421 | |
| Domain | fn3 | 1.05e-03 | 162 | 235 | 8 | PF00041 | |
| Domain | - | DCAF6 WDR17 PLXNA1 PLXNB3 FBXW11 WDR72 WDFY4 WDPCP ARHGEF10L NBAS LRBA WDTC1 | 1.09e-03 | 333 | 235 | 12 | 2.130.10.10 |
| Domain | WD40/YVTN_repeat-like_dom | DCAF6 WDR17 PLXNA1 PLXNB3 FBXW11 WDR72 WDFY4 WDPCP ARHGEF10L NBAS LRBA WDTC1 | 1.15e-03 | 335 | 235 | 12 | IPR015943 |
| Domain | Small_GTPase_Ras | 1.16e-03 | 37 | 235 | 4 | IPR020849 | |
| Domain | - | SPTBN1 PTPN3 OSBPL7 VEPH1 TRIOBP CIT CDC42BPB ARHGEF10L ARHGEF40 PLEKHO2 PLCH1 EPB41L1 PLCE1 | 1.42e-03 | 391 | 235 | 13 | 2.30.29.30 |
| Domain | TYR_PHOSPHATASE_PTP | 1.42e-03 | 39 | 235 | 4 | PS50055 | |
| Domain | IG_LIKE | HLA-A HAPLN2 DSCAML1 PTPRD BSG KIT MYOM3 IL1RAPL1 CD1C BTNL2 CD47 CD300LG MYOM2 PALLD MYBPC1 | 1.45e-03 | 491 | 235 | 15 | PS50835 |
| Domain | Biotin_BS | 1.54e-03 | 5 | 235 | 2 | IPR001882 | |
| Domain | Laminin_domII | 1.54e-03 | 5 | 235 | 2 | IPR010307 | |
| Domain | Biotin_COase_C | 1.54e-03 | 5 | 235 | 2 | IPR005482 | |
| Domain | BC | 1.54e-03 | 5 | 235 | 2 | PS50979 | |
| Domain | Laminin_aI | 1.54e-03 | 5 | 235 | 2 | IPR009254 | |
| Domain | Laminin_I | 1.54e-03 | 5 | 235 | 2 | PF06008 | |
| Domain | Laminin_II | 1.54e-03 | 5 | 235 | 2 | PF06009 | |
| Domain | Biotin_carb_C | 1.54e-03 | 5 | 235 | 2 | SM00878 | |
| Domain | Biotin_carb_C | 1.54e-03 | 5 | 235 | 2 | PF02785 | |
| Domain | Biotin_carboxylation_dom | 1.54e-03 | 5 | 235 | 2 | IPR011764 | |
| Domain | BIOTIN | 1.54e-03 | 5 | 235 | 2 | PS00188 | |
| Domain | PTPase_domain | 1.72e-03 | 41 | 235 | 4 | IPR000242 | |
| Domain | Y_phosphatase | 1.72e-03 | 41 | 235 | 4 | PF00102 | |
| Domain | Ig-like_dom | HLA-A HAPLN2 DSCAML1 PTPRD BSG KIT MYOM3 IL1RAPL1 CD1C BTNL2 CD47 CD300LG MYOM2 PALLD MYBPC1 | 1.84e-03 | 503 | 235 | 15 | IPR007110 |
| Pathway | REACTOME_CONSTITUTIVE_SIGNALING_BY_OVEREXPRESSED_ERBB2 | 7.74e-06 | 11 | 179 | 4 | M29814 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_EGFR_RAS_RALGDS_SIGNALING_PATHWAY | 7.74e-06 | 11 | 179 | 4 | M47436 | |
| Pathway | REACTOME_RAS_PROCESSING | 1.09e-05 | 24 | 179 | 5 | M38995 | |
| Pathway | WP_RALA_DOWNSTREAM_REGULATED_GENES | 1.15e-05 | 12 | 179 | 4 | M39408 | |
| Pathway | REACTOME_P38MAPK_EVENTS | 1.64e-05 | 13 | 179 | 4 | M1441 | |
| Pathway | REACTOME_ACTIVATION_OF_RAS_IN_B_CELLS | 1.98e-05 | 5 | 179 | 3 | M26921 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_KIT_TO_RAS_ERK_SIGNALING_PATHWAY | 2.28e-05 | 14 | 179 | 4 | M47365 | |
| Pathway | REACTOME_PTK6_REGULATES_RHO_GTPASES_RAS_GTPASE_AND_MAP_KINASES | 2.28e-05 | 14 | 179 | 4 | M27734 | |
| Pathway | PID_MTOR_4PATHWAY | 2.63e-05 | 69 | 179 | 7 | M121 | |
| Pathway | WP_GPCRS_CLASS_C_METABOTROPIC_GLUTAMATE_PHEROMONE | 3.08e-05 | 15 | 179 | 4 | MM15845 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_PYK2_RAS_ERK_SIGNALING_PATHWAY | 3.08e-05 | 15 | 179 | 4 | M47592 | |
| Pathway | WP_GPCRS_CLASS_C_METABOTROPIC_GLUTAMATE_PHEROMONE | 3.08e-05 | 15 | 179 | 4 | M39442 | |
| Pathway | KEGG_MEDICUS_REFERENCE_KITLG_KIT_RAS_ERK_SIGNALING_PATHWAY | 3.08e-05 | 15 | 179 | 4 | M47472 | |
| Pathway | REACTOME_ESTROGEN_STIMULATED_SIGNALING_THROUGH_PRKCZ | 3.92e-05 | 6 | 179 | 3 | M27951 | |
| Pathway | KEGG_MEDICUS_VARIANT_LOSS_OF_RASSF1_TO_RAS_RASSF1_SIGNALING_PATHWAY | 3.92e-05 | 6 | 179 | 3 | M47433 | |
| Pathway | KEGG_MEDICUS_REFERENCE_REGULATION_OF_GF_RTK_RAS_ERK_SIGNALING_RAS_UBIQUITINATION_BY_CUL3_COMPLEX | 3.92e-05 | 6 | 179 | 3 | M47931 | |
| Pathway | KEGG_MEDICUS_REFERENCE_REGULATION_OF_GF_RTK_RAS_ERK_SIGNALING_SPRED_AND_NF1 | 3.92e-05 | 6 | 179 | 3 | M47932 | |
| Pathway | REACTOME_SIGNALING_BY_ERBB2_ECD_MUTANTS | 4.06e-05 | 16 | 179 | 4 | M29847 | |
| Pathway | WP_INHIBITION_OF_EXOSOME_BIOGENESIS_AND_SECRETION_BY_MANUMYCIN_A_IN_CRPC_CELLS | 6.69e-05 | 18 | 179 | 4 | M39737 | |
| Pathway | REACTOME_RAS_SIGNALING_DOWNSTREAM_OF_NF1_LOSS_OF_FUNCTION_VARIANTS | 6.79e-05 | 7 | 179 | 3 | M29717 | |
| Pathway | REACTOME_SOS_MEDIATED_SIGNALLING | 6.79e-05 | 7 | 179 | 3 | M19489 | |
| Pathway | REACTOME_P38MAPK_EVENTS | 6.79e-05 | 7 | 179 | 3 | MM14672 | |
| Pathway | REACTOME_SIGNALING_BY_FLT3_FUSION_PROTEINS | 8.39e-05 | 19 | 179 | 4 | M41732 | |
| Pathway | PID_PI3K_PLC_TRK_PATHWAY | 8.55e-05 | 36 | 179 | 5 | M271 | |
| Pathway | REACTOME_RAS_ACTIVATION_UPON_CA2_INFLUX_THROUGH_NMDA_RECEPTOR | 1.04e-04 | 20 | 179 | 4 | M17670 | |
| Pathway | REACTOME_SIGNALING_BY_KIT_IN_DISEASE | 1.04e-04 | 20 | 179 | 4 | M39002 | |
| Pathway | REACTOME_SIGNALLING_TO_RAS | 1.04e-04 | 20 | 179 | 4 | M12256 | |
| Pathway | REACTOME_ACTIVATED_NTRK3_SIGNALS_THROUGH_RAS | 1.08e-04 | 8 | 179 | 3 | M27919 | |
| Pathway | KEGG_MEDICUS_REFERENCE_REGULATION_OF_GF_RTK_RAS_ERK_SIGNALING_RASGAP | 1.08e-04 | 8 | 179 | 3 | M47935 | |
| Pathway | REACTOME_EGFR_TRANSACTIVATION_BY_GASTRIN | 1.60e-04 | 9 | 179 | 3 | M27156 | |
| Pathway | REACTOME_SHC_RELATED_EVENTS_TRIGGERED_BY_IGF1R | 1.60e-04 | 9 | 179 | 3 | M27173 | |
| Pathway | REACTOME_ACTIVATED_NTRK2_SIGNALS_THROUGH_RAS | 1.60e-04 | 9 | 179 | 3 | M27904 | |
| Pathway | WP_BIOTIN_METABOLISM_INCLUDING_IMDS | 1.60e-04 | 9 | 179 | 3 | M40064 | |
| Pathway | REACTOME_NEGATIVE_REGULATION_OF_MAPK_PATHWAY | 2.03e-04 | 43 | 179 | 5 | M27560 | |
| Pathway | REACTOME_MAPK_FAMILY_SIGNALING_CASCADES | ABHD17A SPTBN1 PTPN3 PTPRA PSME4 HRAS LRRC7 KIT KRAS RALGDS NRAS FNTB PPP2R5E | 2.80e-04 | 327 | 179 | 13 | M27565 |
| Pathway | REACTOME_SIGNALING_BY_ERBB2_IN_CANCER | 3.02e-04 | 26 | 179 | 4 | M29535 | |
| Pathway | REACTOME_SIGNALING_BY_FGFR4_IN_DISEASE | 3.08e-04 | 11 | 179 | 3 | M27535 | |
| Pathway | KEGG_MEDICUS_VARIANT_RET_FUSION_KINASE_TO_RAS_ERK_SIGNALING_PATHWAY | 3.08e-04 | 11 | 179 | 3 | M47370 | |
| Pathway | KEGG_MEDICUS_VARIANT_TRK_FUSION_KINASE_TO_RAS_ERK_SIGNALING_PATHWAY | 3.08e-04 | 11 | 179 | 3 | M47371 | |
| Pathway | REACTOME_BIOTIN_TRANSPORT_AND_METABOLISM | 3.08e-04 | 11 | 179 | 3 | M27086 | |
| Pathway | REACTOME_BIOTIN_TRANSPORT_AND_METABOLISM | 3.08e-04 | 11 | 179 | 3 | MM14764 | |
| Pathway | REACTOME_ACTIVATED_NTRK2_SIGNALS_THROUGH_FRS2_AND_FRS3 | 3.08e-04 | 11 | 179 | 3 | M27911 | |
| Pathway | REACTOME_MET_ACTIVATES_RAS_SIGNALING | 3.08e-04 | 11 | 179 | 3 | M27740 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_EGFR_RAS_RASSF1_SIGNALING_PATHWAY | 3.08e-04 | 11 | 179 | 3 | M47432 | |
| Pathway | REACTOME_STIMULI_SENSING_CHANNELS | 4.01e-04 | 106 | 179 | 7 | M27200 | |
| Pathway | REACTOME_CREB1_PHOSPHORYLATION_THROUGH_NMDA_RECEPTOR_MEDIATED_ACTIVATION_OF_RAS_SIGNALING | 4.06e-04 | 28 | 179 | 4 | M837 | |
| Pathway | REACTOME_FLT3_SIGNALING_IN_DISEASE | 4.06e-04 | 28 | 179 | 4 | M41724 | |
| Pathway | REACTOME_TRP_CHANNELS | 4.06e-04 | 28 | 179 | 4 | MM14943 | |
| Pathway | REACTOME_TRP_CHANNELS | 4.06e-04 | 28 | 179 | 4 | M27241 | |
| Pathway | KEGG_MEDICUS_VARIANT_EML4_ALK_FUSION_KINASE_TO_RAS_ERK_SIGNALING_PATHWAY | 4.07e-04 | 12 | 179 | 3 | M47369 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_METALS_TO_RAS_ERK_SIGNALING_PATHWAY | 4.07e-04 | 12 | 179 | 3 | M47815 | |
| Pathway | REACTOME_SIGNALLING_TO_RAS | 4.07e-04 | 12 | 179 | 3 | MM14657 | |
| Pathway | REACTOME_SIGNALING_BY_PDGFRA_TRANSMEMBRANE_JUXTAMEMBRANE_AND_KINASE_DOMAIN_MUTANTS | 4.07e-04 | 12 | 179 | 3 | M29851 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_EGFR_RAS_JNK_SIGNALING_PATHWAY | 5.24e-04 | 13 | 179 | 3 | M47594 | |
| Pathway | REACTOME_PTK6_REGULATES_RHO_GTPASES_RAS_GTPASE_AND_MAP_KINASES | 5.24e-04 | 13 | 179 | 3 | MM15484 | |
| Pathway | PID_RAS_PATHWAY | 5.32e-04 | 30 | 179 | 4 | M269 | |
| Pathway | REACTOME_ION_CHANNEL_TRANSPORT | 5.50e-04 | 183 | 179 | 9 | M997 | |
| Pathway | REACTOME_RHO_GTPASE_CYCLE | MYO6 USP9X SPTBN1 ERBIN PTK2B ARHGAP8 PLXNA1 RRAS2 SLC4A7 OCRL ARHGAP35 CIT CDC42BPB ARHGEF10L ARHGEF40 | 6.26e-04 | 450 | 179 | 15 | M27078 |
| Pathway | REACTOME_SENSORY_PROCESSING_OF_SOUND_BY_OUTER_HAIR_CELLS_OF_THE_COCHLEA | 6.50e-04 | 55 | 179 | 5 | M41823 | |
| Pathway | KEGG_MEDICUS_VARIANT_BCR_ABL_FUSION_KINASE_TO_RAS_ERK_SIGNALING_PATHWAY | 6.61e-04 | 14 | 179 | 3 | M47364 | |
| Pathway | KEGG_MEDICUS_VARIANT_DUPLICATION_OR_MUTATION_ACTIVATED_FLT3_TO_RAS_ERK_SIGNALING_PATHWAY | 6.61e-04 | 14 | 179 | 3 | M47366 | |
| Pathway | KEGG_MEDICUS_VARIANT_DUPLICATION_OR_MUTATION_ACTIVATED_FLT3_TO_RAS_PI3K_SIGNALING_PATHWAY | 6.61e-04 | 14 | 179 | 3 | M47390 | |
| Pathway | KEGG_MEDICUS_VARIANT_AMPLIFIED_PDGFR_TO_RAS_ERK_SIGNALING_PATHWAY | 6.61e-04 | 14 | 179 | 3 | M47378 | |
| Pathway | REACTOME_SHC1_EVENTS_IN_ERBB4_SIGNALING | 6.61e-04 | 14 | 179 | 3 | M569 | |
| Pathway | REACTOME_ERYTHROPOIETIN_ACTIVATES_RAS | 6.61e-04 | 14 | 179 | 3 | M27908 | |
| Pathway | PID_TCR_RAS_PATHWAY | 6.61e-04 | 14 | 179 | 3 | M134 | |
| Pathway | KEGG_MEDICUS_VARIANT_MET_OVEREXPRESSION_TO_RAS_ERK_SIGNALING_PATHWAY | 6.61e-04 | 14 | 179 | 3 | M47488 | |
| Pathway | REACTOME_SHC1_EVENTS_IN_EGFR_SIGNALING | 6.61e-04 | 14 | 179 | 3 | M719 | |
| Pathway | REACTOME_DEVELOPMENTAL_BIOLOGY | KRT26 SPTBN1 DSCAML1 KRT39 PTPRA HRAS KIT KRT25 PLXNA1 PLXNB3 KRAS DPYSL2 KRT34 KRT35 KRT28 ARHGAP35 | 6.70e-04 | 502 | 179 | 16 | MM14537 |
| Pathway | REACTOME_MAPK_FAMILY_SIGNALING_CASCADES | ABHD17A SPTBN1 PTPN3 PTPRA PSME4 HRAS LRRC7 KIT KRAS RALGDS FNTB PPP2R5E | 7.60e-04 | 318 | 179 | 12 | MM15278 |
| Pathway | REACTOME_CONSTITUTIVE_SIGNALING_BY_EGFRVIII | 8.19e-04 | 15 | 179 | 3 | M29701 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_MET_TO_RAS_ERK_SIGNALING_PATHWAY | 8.19e-04 | 15 | 179 | 3 | M47367 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_EGFR_RAS_PI3K_SIGNALING_PATHWAY | 8.19e-04 | 15 | 179 | 3 | M47389 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_EGFR_TO_RAS_ERK_SIGNALING_PATHWAY | 8.19e-04 | 15 | 179 | 3 | M47375 | |
| Pathway | KEGG_MEDICUS_VARIANT_AMPLIFIED_FGFR_TO_RAS_ERK_SIGNALING_PATHWAY | 8.19e-04 | 15 | 179 | 3 | M47380 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HBV_HBX_TO_RAS_ERK_SIGNALING_PATHWAY | 8.19e-04 | 15 | 179 | 3 | M47593 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_FGF17_TO_RAS_ERK_SIGNALING_PATHWAY | 8.19e-04 | 15 | 179 | 3 | M47640 | |
| Pathway | KEGG_MEDICUS_VARIANT_IGF2_OVEREXPRESSION_TO_RAS_ERK_SIGNALING_PATHWAY | 8.19e-04 | 15 | 179 | 3 | M47485 | |
| Pathway | KEGG_MEDICUS_REFERENCE_HGF_MET_RAS_ERK_SIGNALING_PATHWAY | 8.19e-04 | 15 | 179 | 3 | M47473 | |
| Pathway | KEGG_MEDICUS_REFERENCE_FLT3LG_FLT3_RAS_ERK_SIGNALING_PATHWAY | 8.19e-04 | 15 | 179 | 3 | M47474 | |
| Pathway | KEGG_MEDICUS_REFERENCE_FLT3LG_FLT3_RAS_PI3K_SIGNALING_PATHWAY | 8.19e-04 | 15 | 179 | 3 | M47475 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TGFA_EGFR_RAS_ERK_SIGNALING_PATHWAY | 8.19e-04 | 15 | 179 | 3 | M47480 | |
| Pathway | KEGG_MEDICUS_VARIANT_EGF_OVEREXPRESSION_TO_RAS_ERK_SIGNALING_PATHWAY | 8.19e-04 | 15 | 179 | 3 | M47495 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EREG_EGFR_RAS_ERK_SIGNALING_PATHWAY | 8.19e-04 | 15 | 179 | 3 | M47496 | |
| Pathway | KEGG_MEDICUS_REFERENCE_AREG_EGFR_RAS_ERK_SIGNALING_PATHWAY | 8.19e-04 | 15 | 179 | 3 | M47497 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HCMV_GB_TO_PDGFR_RAS_ERK_SIGNALING_PATHWAY | 8.19e-04 | 15 | 179 | 3 | M47535 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E5_TO_EGFR_RAS_ERK_SIGNALING_PATHWAY | 8.19e-04 | 15 | 179 | 3 | M47531 | |
| Pathway | REACTOME_FORMATION_OF_THE_CORNIFIED_ENVELOPE | 8.31e-04 | 87 | 179 | 6 | MM15351 | |
| Pathway | REACTOME_RAF_ACTIVATION | 8.66e-04 | 34 | 179 | 4 | M27556 | |
| Pathway | REACTOME_SIGNALLING_TO_ERKS | 8.66e-04 | 34 | 179 | 4 | M13881 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_EGFR_RAS_ERK_SIGNALING_PATHWAY | 9.98e-04 | 16 | 179 | 3 | M47363 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_FGFR3_TO_RAS_ERK_SIGNALING_PATHWAY | 9.98e-04 | 16 | 179 | 3 | M47373 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_ERBB2_RAS_ERK_SIGNALING_PATHWAY | 9.98e-04 | 16 | 179 | 3 | M47381 | |
| Pathway | KEGG_MEDICUS_REFERENCE_P4_PR_RAS_ERK_SIGNALING_PATHWAY | 9.98e-04 | 16 | 179 | 3 | M47804 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_E2_TO_RAS_ERK_SIGNALING_PATHWAY | 9.98e-04 | 16 | 179 | 3 | M47801 | |
| Pathway | REACTOME_GRB2_EVENTS_IN_ERBB2_SIGNALING | 9.98e-04 | 16 | 179 | 3 | M562 | |
| Pathway | REACTOME_SIGNALING_BY_FLT3_ITD_AND_TKD_MUTANTS | 9.98e-04 | 16 | 179 | 3 | M41733 | |
| Pathway | KEGG_MEDICUS_REFERENCE_AGE_RAGE_SIGNALING_PATHWAY | 9.98e-04 | 16 | 179 | 3 | M47682 | |
| Pathway | KEGG_MEDICUS_REFERENCE_IGF_IGF1R_RAS_ERK_SIGNALING_PATHWAY | 9.98e-04 | 16 | 179 | 3 | M47483 | |
| Pathway | REACTOME_CLASS_C_3_METABOTROPIC_GLUTAMATE_PHEROMONE_RECEPTORS | 1.20e-03 | 37 | 179 | 4 | MM15067 | |
| Pubmed | DCAF6 HLA-A MYO6 DIS3L EIF4A3 USP9X SPTBN1 HLCS RNF40 RRBP1 DSCAML1 TERF2IP NELL1 PTPRA WIZ PTPRD VPS35L PLEC WDR17 HECTD1 PLXNB3 CAP2 FBXW11 DPYSL2 TRIOBP CIT CDC42BPB AKAP8L FRY PPP2R5E LMO2 TRIM9 EIF4A1 KDM4A LRBA TBC1D23 PC ZNF292 PCNT | 6.64e-15 | 1285 | 239 | 39 | 35914814 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | RNF40 ANKLE1 JADE1 RYR1 WIZ PSME4 CCDC3 AP1G2 RIPOR1 PLEC HECTD1 PLXNA1 GAREM1 TEAD2 FNTB AOC2 MYOM3 LAMA5 GRID1 ARHGAP35 CIT CDC42BPB ARHGEF10L ARHGEF40 PLEKHO2 LRBA HAS3 PC PCNT | 7.82e-10 | 1105 | 239 | 29 | 35748872 |
| Pubmed | KIFBP EIF4A3 RNF40 JADE1 ADGRV1 RRBP1 PSME4 MRC2 FBXO41 YWHAQ RALGDS TRIOBP LAMA5 SPG11 ANKRD50 ARHGEF10L TRIM9 KDM4A EXOSC7 NIN | 9.54e-10 | 529 | 239 | 20 | 14621295 | |
| Pubmed | 1.81e-09 | 9 | 239 | 5 | 10783161 | ||
| Pubmed | The RAS-Effector Interface: Isoform-Specific Differences in the Effector Binding Regions. | 2.17e-09 | 4 | 239 | 4 | 27936046 | |
| Pubmed | Activated Ras interacts with the Ral guanine nucleotide dissociation stimulator. | 2.17e-09 | 4 | 239 | 4 | 7972015 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | BDP1 DCAF6 TRPC4AP MYO6 ATP8B1 ADGRV1 RRBP1 ME2 ERBIN TERF2IP LMLN VPS35L RIPOR1 LRRC7 ARHGAP8 HECTD1 CAP2 FBXW11 ENOSF1 UBR2 DPYSL2 MBLAC2 LAMA3 TRIOBP PELI2 ARHGAP35 CDC42BPB IFRD1 KNDC1 LRBA EPB41L1 PCNT XPO7 | 3.37e-09 | 1489 | 239 | 33 | 28611215 |
| Pubmed | Large-scale mapping of human protein-protein interactions by mass spectrometry. | KIFBP FAM120B HLA-A MYO6 USP9X DHX38 PFKFB3 RRBP1 PTP4A1 CDAN1 PTPN3 BSG PDS5A LRRC7 YWHAQ FBXW11 SLC4A7 FNTB FXR2 KRT34 KRT35 GSKIP PSTPIP1 CDC42BPB AKAP8L PPM1B EIF4A1 MRPS5 LRBA XPO7 | 5.71e-09 | 1284 | 239 | 30 | 17353931 |
| Pubmed | KIFBP USP9X SPTBN1 LMTK3 ERBIN WIZ PTPRD ANAPC1 HRAS FBXO41 LRRC7 YWHAQ CAP2 KRAS DPYSL2 SLC4A8 FXR2 TRIOBP GRM3 CIT CDC42BPB FRY EIF4A1 EPB41L1 PCNT | 1.55e-08 | 963 | 239 | 25 | 28671696 | |
| Pubmed | HLA-A USP9X SPTBN1 DHX38 ERBIN PTP4A1 PTPN3 PTPRA WIZ PTPRD BSG YWHAQ HSPA6 CAP2 FBXW11 UBR2 PPM1E TRIOBP CDC42BPB AKAP8L PPM1B PPP2R5E PC EPB41L1 PCNT NIN | 1.99e-08 | 1049 | 239 | 26 | 27880917 | |
| Pubmed | MYO6 DIS3L DHX38 SCAPER PDS5A HECTD1 PDZRN4 SLC4A8 TBC1D30 ARHGAP35 WDFY4 CDC42BPB ZNF665 PLCH1 PALLD PDZRN3 UNC80 | 6.80e-08 | 493 | 239 | 17 | 15368895 | |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | MYO6 DIS3L RRBP1 DHX8 WIZ ANAPC1 SMG9 PLEC ASCC3 TADA3 DPYSL2 FXR2 TRIOBP OCRL ARHGAP35 CDC42BPB POLR3C EXOSC7 PALLD ZNF292 | 1.72e-07 | 724 | 239 | 20 | 36232890 |
| Pubmed | 2.58e-07 | 127 | 239 | 9 | 30442766 | ||
| Pubmed | The deubiquitinase TRABID stabilizes the K29/K48-specific E3 ubiquitin ligase HECTD1. | MYO6 PSME4 GCLC ANAPC1 PDS5A HECTD1 FBXW11 UBR2 TRIM62 PCNT WDTC1 | 2.86e-07 | 212 | 239 | 11 | 33853758 |
| Pubmed | Diagnostic Value of RAS Mutations in Indeterminate Thyroid Nodules. | 3.20e-07 | 3 | 239 | 3 | 28116986 | |
| Pubmed | Mutations of RAS gene family in specimens of bladder cancer. | 3.20e-07 | 3 | 239 | 3 | 19101897 | |
| Pubmed | 3.20e-07 | 3 | 239 | 3 | 33620658 | ||
| Pubmed | 3.20e-07 | 3 | 239 | 3 | 22589270 | ||
| Pubmed | A requirement for wild-type Ras isoforms in mutant KRas-driven signalling and transformation. | 3.20e-07 | 3 | 239 | 3 | 23496764 | |
| Pubmed | Distribution of p21ras during primary palate formation of non-cleft and cleft strains of mice. | 3.20e-07 | 3 | 239 | 3 | 7776260 | |
| Pubmed | 3.20e-07 | 3 | 239 | 3 | 25801914 | ||
| Pubmed | 3.20e-07 | 3 | 239 | 3 | 25788415 | ||
| Pubmed | Comparison of liver oncogenic potential among human RAS isoforms. | 3.20e-07 | 3 | 239 | 3 | 26799184 | |
| Pubmed | 3.20e-07 | 3 | 239 | 3 | 31906952 | ||
| Pubmed | Partial functional overlap of the three ras genes in mouse embryonic development. | 3.20e-07 | 3 | 239 | 3 | 18059342 | |
| Pubmed | Evidence of a low prevalence of RAS mutations in a large medullary thyroid cancer series. | 3.20e-07 | 3 | 239 | 3 | 23240926 | |
| Pubmed | Absolute Quantification of Endogenous Ras Isoform Abundance. | 3.20e-07 | 3 | 239 | 3 | 26560143 | |
| Pubmed | Further evidence for a somatic KRAS mutation in a pilocytic astrocytoma. | 3.20e-07 | 3 | 239 | 3 | 17712732 | |
| Pubmed | 3.20e-07 | 3 | 239 | 3 | 24222113 | ||
| Pubmed | Interactions between wild-type and mutant Ras genes in lung and skin carcinogenesis. | 3.20e-07 | 3 | 239 | 3 | 22945650 | |
| Pubmed | 3.20e-07 | 3 | 239 | 3 | 19303097 | ||
| Pubmed | 3.20e-07 | 3 | 239 | 3 | 27911734 | ||
| Pubmed | Absence of oncogenic mutations of RAS family genes in soft tissue sarcomas of 100 Japanese patients. | 3.20e-07 | 3 | 239 | 3 | 20150643 | |
| Pubmed | K-ras is an essential gene in the mouse with partial functional overlap with N-ras. | 3.20e-07 | 3 | 239 | 3 | 9334313 | |
| Pubmed | RAS gene mutations and histomorphometric measurements in oral squamous cell carcinoma. | 3.20e-07 | 3 | 239 | 3 | 37013448 | |
| Pubmed | 3.20e-07 | 3 | 239 | 3 | 25977330 | ||
| Pubmed | 3.20e-07 | 3 | 239 | 3 | 28630043 | ||
| Pubmed | Overexpression of wild-type p21Ras plays a prominent role in colorectal cancer. | 3.20e-07 | 3 | 239 | 3 | 28259994 | |
| Pubmed | The variable phenotype and low-risk nature of RAS-positive thyroid nodules. | 3.20e-07 | 3 | 239 | 3 | 26253102 | |
| Pubmed | 3.20e-07 | 3 | 239 | 3 | 16573741 | ||
| Pubmed | Analysis of k-ras nuclear expression in fibroblasts and mesangial cells. | 3.20e-07 | 3 | 239 | 3 | 20090846 | |
| Pubmed | 3.20e-07 | 3 | 239 | 3 | 21737741 | ||
| Pubmed | 3.20e-07 | 3 | 239 | 3 | 17943694 | ||
| Pubmed | 3.20e-07 | 3 | 239 | 3 | 28202657 | ||
| Pubmed | Mutational analysis of K-ras and Ras protein expression in larynx squamous cell carcinoma. | 3.20e-07 | 3 | 239 | 3 | 16761621 | |
| Pubmed | 3.20e-07 | 3 | 239 | 3 | 20971740 | ||
| Pubmed | 3.20e-07 | 3 | 239 | 3 | 27119512 | ||
| Pubmed | ACACB USP9X SPTBN1 RRBP1 ERBIN BSG FBXO41 LRRC7 YWHAQ PLEC DPYSL2 SLC4A7 SLC4A8 FXR2 ATG2B TRIOBP ARHGAP35 CIT CDC42BPB AKAP8L TRIM9 KNDC1 MRPS5 PC EPB41L1 | 3.74e-07 | 1139 | 239 | 25 | 36417873 | |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | BDP1 ACACB MYO6 USP9X SPTBN1 RRBP1 BSG ASCC3 SPG11 AKAP8L DNAH12 KDM4A MYOM2 LRBA HYDIN ZNF292 | 4.18e-07 | 497 | 239 | 16 | 36774506 |
| Pubmed | Expression cloning of GABA(B) receptors uncovers similarity to metabotropic glutamate receptors. | 4.42e-07 | 10 | 239 | 4 | 9069281 | |
| Pubmed | 4.42e-07 | 10 | 239 | 4 | 34215617 | ||
| Pubmed | 4.42e-07 | 10 | 239 | 4 | 15451670 | ||
| Pubmed | ADGRV1 RRBP1 ERBIN DSCAML1 TRIOBP ARHGAP35 CDC42BPB TRIM9 UNC80 PCNT NIN | 5.16e-07 | 225 | 239 | 11 | 12168954 | |
| Pubmed | HLA-A MYO6 USP9X SPTBN1 HLCS RRBP1 ERBIN BSG PDS5A LRRC7 ASCC3 ATG2B OCRL ANKRD50 LRBA PLCH1 SMCR8 PALLD EPB41L1 | 5.45e-07 | 708 | 239 | 19 | 39231216 | |
| Pubmed | FAM120B USP9X MEIOB WIZ ANAPC1 RTL9 SCAPER ASCC3 CIT EIF3J PC EXOSC7 | 6.60e-07 | 281 | 239 | 12 | 24163370 | |
| Pubmed | Human Sos1: a guanine nucleotide exchange factor for Ras that binds to GRB2. | 6.98e-07 | 25 | 239 | 5 | 8493579 | |
| Pubmed | Ras effectors and their role in mitogenesis and oncogenesis. | 1.03e-06 | 12 | 239 | 4 | 9297626 | |
| Pubmed | 1.03e-06 | 12 | 239 | 4 | 15617563 | ||
| Pubmed | 1.28e-06 | 4 | 239 | 3 | 29844052 | ||
| Pubmed | 1.28e-06 | 4 | 239 | 3 | 10085069 | ||
| Pubmed | 1.28e-06 | 4 | 239 | 3 | 38849523 | ||
| Pubmed | 1.28e-06 | 4 | 239 | 3 | 9674433 | ||
| Pubmed | Quantification of spatiotemporal patterns of Ras isoform expression during development. | 1.28e-06 | 4 | 239 | 3 | 28117393 | |
| Pubmed | Reducing Pericyte-Derived Scarring Promotes Recovery after Spinal Cord Injury. | 1.28e-06 | 4 | 239 | 3 | 29502968 | |
| Pubmed | 1.28e-06 | 4 | 239 | 3 | 10490827 | ||
| Pubmed | 1.28e-06 | 4 | 239 | 3 | 17960171 | ||
| Pubmed | Distribution of group-III metabotropic glutamate receptors in the retina. | 1.28e-06 | 4 | 239 | 3 | 17311335 | |
| Pubmed | Tyrosine phosphorylation of RAS by ABL allosterically enhances effector binding. | 1.28e-06 | 4 | 239 | 3 | 25999467 | |
| Pubmed | 1.28e-06 | 4 | 239 | 3 | 34948093 | ||
| Pubmed | Ras membrane orientation and nanodomain localization generate isoform diversity. | 1.28e-06 | 4 | 239 | 3 | 20080631 | |
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | MYO6 RRBP1 ANAPC1 PLEC ASCC3 HECTD1 CIT CDC42BPB NBAS ARHGEF40 | 1.53e-06 | 202 | 239 | 10 | 33005030 |
| Pubmed | IL12RB1 FAM120B MYO6 USP9X SPTBN1 HAPLN2 RRBP1 ERBIN PTK2B PTPRA SCAPER FBXO41 HRG LRRC7 YWHAQ PLEC DPYSL2 ARHGAP35 GRM3 CIT CDC42BPB PPP2R5E TRIM9 KNDC1 PLCH1 PC EPB41L1 | 2.27e-06 | 1431 | 239 | 27 | 37142655 | |
| Pubmed | Cooperative polarization of MCAM/CD146 and ERM family proteins in melanoma. | HLA-A MYO6 SPTBN1 ERBIN PTPN3 PTPRA BSG SLC4A7 ANKRD50 CDC42BPB PLEKHO2 TRPV4 EPB41L1 | 2.46e-06 | 377 | 239 | 13 | 38117590 |
| Pubmed | 3.17e-06 | 5 | 239 | 3 | 22982107 | ||
| Pubmed | 3.17e-06 | 5 | 239 | 3 | 9069260 | ||
| Pubmed | Pericyte-derived fibrotic scarring is conserved across diverse central nervous system lesions. | 3.17e-06 | 5 | 239 | 3 | 34535655 | |
| Pubmed | 3.17e-06 | 5 | 239 | 3 | 21131919 | ||
| Pubmed | 3.17e-06 | 5 | 239 | 3 | 6364482 | ||
| Pubmed | 3.17e-06 | 5 | 239 | 3 | 7809086 | ||
| Pubmed | Impeded Nedd4-1-mediated Ras degradation underlies Ras-driven tumorigenesis. | 3.17e-06 | 5 | 239 | 3 | 24746824 | |
| Pubmed | 3.17e-06 | 5 | 239 | 3 | 27391150 | ||
| Pubmed | Activated Ras induces lens epithelial cell hyperplasia but not premature differentiation. | 3.17e-06 | 5 | 239 | 3 | 15558479 | |
| Pubmed | DCAF6 DIS3L ABCA12 HLCS GCDH WIZ BRDT ANAPC1 RTL9 SCAPER ASCC3 TADA3 WDR72 FXR2 AKAP8L GTPBP2 ARHGEF40 PPP2R5E PDZRN3 UNC80 SORL1 WDTC1 NIN | 3.21e-06 | 1116 | 239 | 23 | 31753913 | |
| Pubmed | 4.84e-06 | 63 | 239 | 6 | 16831889 | ||
| Pubmed | DHX38 ERBIN TERF2IP DHX8 WIZ ANAPC1 PDS5A YWHAQ ASCC3 TADA3 HSPA6 SLC4A7 NRAS TBC1D30 TRIOBP LAMA5 CIT CDC42BPB AKAP8L IFRD1 PPP2R5E EIF4A1 MRPS5 EXOC2 EIF3J EXOSC7 EPB41L1 | 5.21e-06 | 1497 | 239 | 27 | 31527615 | |
| Pubmed | HLA-A MYO6 EIF4A3 SPTBN1 RRBP1 ERBIN DHX8 ADSL BSG HRAS YWHAQ ASCC3 HECTD1 FBXW11 KRAS UBR2 RRAS2 FXR2 GSKIP CIT AKAP8L PPM1B EIF4A1 EIF3J | 6.19e-06 | 1247 | 239 | 24 | 27684187 | |
| Pubmed | Glutamate transporter Slc1a3 mediates inter-niche stem cell activation during skin growth. | 6.31e-06 | 6 | 239 | 3 | 29615452 | |
| Pubmed | Pias1 interaction and sumoylation of metabotropic glutamate receptor 8. | 6.31e-06 | 6 | 239 | 3 | 16144832 | |
| Pubmed | 6.31e-06 | 6 | 239 | 3 | 9753431 | ||
| Pubmed | 6.31e-06 | 6 | 239 | 3 | 21072204 | ||
| Pubmed | 6.31e-06 | 6 | 239 | 3 | 10882715 | ||
| Pubmed | LZTR1 facilitates polyubiquitination and degradation of RAS-GTPases. | 6.31e-06 | 6 | 239 | 3 | 31337872 | |
| Pubmed | The Ras-like protein R-Ras2/TC21 is important for proper mammary gland development. | 1.10e-05 | 7 | 239 | 3 | 22535521 | |
| Pubmed | 1.10e-05 | 7 | 239 | 3 | 20526288 | ||
| Pubmed | 1.10e-05 | 7 | 239 | 3 | 20012784 | ||
| Pubmed | Impaired Proteolysis of Noncanonical RAS Proteins Drives Clonal Hematopoietic Transformation. | 1.10e-05 | 7 | 239 | 3 | 35904492 | |
| Pubmed | SmgGDS displays differential binding and exchange activity towards different Ras isoforms. | 1.10e-05 | 7 | 239 | 3 | 11948427 | |
| Pubmed | 1.10e-05 | 7 | 239 | 3 | 20860430 | ||
| Pubmed | 1.10e-05 | 7 | 239 | 3 | 22199277 | ||
| Pubmed | 1.10e-05 | 7 | 239 | 3 | 18701070 | ||
| Interaction | TMEM230 interactions | 9.47e-07 | 46 | 234 | 7 | int:TMEM230 | |
| Interaction | TRPV2 interactions | 3.52e-06 | 10 | 234 | 4 | int:TRPV2 | |
| Interaction | FNTB interactions | 4.07e-06 | 106 | 234 | 9 | int:FNTB | |
| Interaction | NAV2 interactions | 9.78e-06 | 43 | 234 | 6 | int:NAV2 | |
| Interaction | KRT71 interactions | 9.78e-06 | 43 | 234 | 6 | int:KRT71 | |
| Interaction | MCAM interactions | HLA-A MYO6 SPTBN1 ERBIN PTK2B PTPN3 PTPRA BSG HRAS ATP11C KRAS SLC4A7 NRAS ANKRD50 CDC42BPB PLEKHO2 TRPV4 EPB41L1 | 9.81e-06 | 468 | 234 | 18 | int:MCAM |
| Interaction | GJA1 interactions | HLA-A MYO6 USP9X SPTBN1 ERBIN BSG YWHAQ KRAS SLC4A7 NRAS OCRL CDC42BPB PPM1B NBAS B3GAT1 LRBA PLCH1 SMCR8 EPB41L1 WDTC1 | 1.67e-05 | 583 | 234 | 20 | int:GJA1 |
| Interaction | PPP5C interactions | ECHDC1 ADSL FBXO41 YWHAQ HSPA6 FXR2 ATG2B DNAJB4 CDC42BPB TRIM9 MAP4K1 KNDC1 WDTC1 | 1.89e-05 | 272 | 234 | 13 | int:PPP5C |
| Interaction | PHLDB1 interactions | 2.12e-05 | 49 | 234 | 6 | int:PHLDB1 | |
| Interaction | PAK6 interactions | 2.21e-05 | 73 | 234 | 7 | int:PAK6 | |
| Interaction | SAMSN1 interactions | 2.89e-05 | 16 | 234 | 4 | int:SAMSN1 | |
| Interaction | CDHR5 interactions | 2.89e-05 | 16 | 234 | 4 | int:CDHR5 | |
| Interaction | HEPH interactions | 3.01e-05 | 6 | 234 | 3 | int:HEPH | |
| Interaction | KRT81 interactions | 3.34e-05 | 53 | 234 | 6 | int:KRT81 | |
| Interaction | TOP3B interactions | MYO6 RNF40 ANKLE1 JADE1 RYR1 WIZ PSME4 CCDC3 AP1G2 RIPOR1 PLEC HECTD1 PLXNA1 GAREM1 TEAD2 FNTB FXR2 AOC2 VEPH1 MYOM3 LAMA5 GRID1 ARHGAP35 CIT CDC42BPB AKAP8L ARHGEF10L ARHGEF40 PLEKHO2 EIF4A1 KDM4A LRBA HAS3 PC PCNT | 3.92e-05 | 1470 | 234 | 35 | int:TOP3B |
| Interaction | HRAS interactions | HLA-A SPTBN1 ERBIN PTPN3 PTPRA ANAPC1 BSG HRAS TRPV2 PDS5A HECTD1 PLXNA1 KRAS RALGDS SLC4A7 NRAS FNTB KNDC1 LRBA EPB41L1 PLCE1 XPO7 | 4.08e-05 | 725 | 234 | 22 | int:HRAS |
| Interaction | TNIK interactions | USP9X SPTBN1 HSPA12B WIZ PTPRD HRAS LRRC7 CAP2 KRAS DPYSL2 NRAS FXR2 PPM1E ANKRD50 CIT | 4.21e-05 | 381 | 234 | 15 | int:TNIK |
| Interaction | UNC5B interactions | 5.51e-05 | 84 | 234 | 7 | int:UNC5B | |
| Interaction | KRT72 interactions | 6.19e-05 | 59 | 234 | 6 | int:KRT72 | |
| Interaction | FBXO22 interactions | BDP1 ACACB MYO6 USP9X SPTBN1 RRBP1 PTP4A1 BSG ASCC3 SPG11 CIT AKAP8L DNAH12 KDM4A MYOM2 LRBA HYDIN ZNF292 | 6.44e-05 | 540 | 234 | 18 | int:FBXO22 |
| Interaction | KRT74 interactions | 6.51e-05 | 37 | 234 | 5 | int:KRT74 | |
| Interaction | PLCE1 interactions | 7.42e-05 | 20 | 234 | 4 | int:PLCE1 | |
| Interaction | KRT3 interactions | 7.43e-05 | 88 | 234 | 7 | int:KRT3 | |
| Interaction | ZFPL1 interactions | HLA-A SPTBN1 ERBIN BSG HRAS OTULINL KRAS SLC4A7 NRAS OCRL PPP2R5E LRBA PLCH1 SMCR8 EPB41L1 WDTC1 | 7.45e-05 | 448 | 234 | 16 | int:ZFPL1 |
| Interaction | KRT85 interactions | 7.49e-05 | 61 | 234 | 6 | int:KRT85 | |
| Interaction | HSPA12A interactions | 8.55e-05 | 121 | 234 | 8 | int:HSPA12A | |
| Interaction | MTDH interactions | TRPC4AP ABCA12 RRBP1 RYR1 MRC2 OTULINL PLEC HECTD1 FXR2 LAMA5 GRID1 ANKRD50 CIT PLEKHO2 B3GAT1 EXOSC7 EPB41L1 | 9.15e-05 | 505 | 234 | 17 | int:MTDH |
| Interaction | TRPM4 interactions | 9.55e-05 | 40 | 234 | 5 | int:TRPM4 | |
| Interaction | KRT80 interactions | 9.82e-05 | 64 | 234 | 6 | int:KRT80 | |
| Interaction | C5orf15 interactions | 1.10e-04 | 22 | 234 | 4 | int:C5orf15 | |
| Interaction | EPHA7 interactions | ERBIN LRRIQ1 PLXNA1 KRAS UBR2 MBLAC2 SLC4A7 NRAS LAMA5 OCRL LRBA PC | 1.20e-04 | 282 | 234 | 12 | int:EPHA7 |
| Interaction | TPD52L1 interactions | 1.21e-04 | 42 | 234 | 5 | int:TPD52L1 | |
| Interaction | SEMA4C interactions | 1.25e-04 | 163 | 234 | 9 | int:SEMA4C | |
| Interaction | HSPA12B interactions | 1.27e-04 | 67 | 234 | 6 | int:HSPA12B | |
| Interaction | RHOD interactions | HLA-A MYO6 USP9X SPTBN1 RRBP1 ERBIN BSG HRAS PLXNA1 KRAS SLC4A7 TRIOBP OCRL ARHGAP35 CDC42BPB LRBA EIF3J EPB41L1 | 1.33e-04 | 572 | 234 | 18 | int:RHOD |
| Interaction | LGALS1 interactions | DCAF6 TRPC4AP PTPRA PTPRD MRC2 HRAS PLXNA1 LAMA5 GRID1 CIT FZD10 SORL1 WDTC1 | 1.44e-04 | 332 | 234 | 13 | int:LGALS1 |
| Interaction | LRRC31 interactions | MYO6 RRBP1 ANAPC1 PLEC ASCC3 HECTD1 CIT CDC42BPB NBAS ARHGEF40 | 1.48e-04 | 205 | 234 | 10 | int:LRRC31 |
| Interaction | MACF1 interactions | DHX38 LRRC7 YWHAQ PLEC HECTD1 KRAS NRAS CIT PPP2R5E LRBA PCNT | 1.55e-04 | 247 | 234 | 11 | int:MACF1 |
| Interaction | PTK7 interactions | 1.57e-04 | 168 | 234 | 9 | int:PTK7 | |
| Interaction | SIRPA interactions | 1.67e-04 | 100 | 234 | 7 | int:SIRPA | |
| Interaction | DSC3 interactions | 2.00e-04 | 103 | 234 | 7 | int:DSC3 | |
| Cytoband | 17q21.2 | 1.86e-06 | 70 | 239 | 6 | 17q21.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr17q21 | KRT26 DHX8 KRT39 OSBPL7 KRT25 KRT34 KRT35 KRT28 AOC2 CD300LG | 2.09e-04 | 473 | 239 | 10 | chr17q21 |
| GeneFamily | Keratins, type I | 2.01e-07 | 28 | 170 | 6 | 608 | |
| GeneFamily | Glutamate metabotropic receptors|Protein phosphatase 1 regulatory subunits | 5.13e-07 | 8 | 170 | 4 | 281 | |
| GeneFamily | Fibronectin type III domain containing|I-set domain containing|Myosin binding proteins | 4.42e-05 | 8 | 170 | 3 | 658 | |
| GeneFamily | Fibronectin type III domain containing | 1.38e-04 | 160 | 170 | 8 | 555 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 1.44e-04 | 161 | 170 | 8 | 593 | |
| GeneFamily | RAS type GTPase family | 1.95e-04 | 31 | 170 | 4 | 389 | |
| GeneFamily | Dyneins, axonemal | 5.04e-04 | 17 | 170 | 3 | 536 | |
| GeneFamily | Transient receptor potential cation channels | 2.25e-03 | 28 | 170 | 3 | 249 | |
| GeneFamily | Immunoglobulin like domain containing | 2.36e-03 | 193 | 170 | 7 | 594 | |
| GeneFamily | WD repeat domain containing|BEACH domain containing | 3.03e-03 | 9 | 170 | 2 | 1230 | |
| GeneFamily | Plexins | 3.03e-03 | 9 | 170 | 2 | 683 | |
| Coexpression | GSE9037_WT_VS_IRAK4_KO_LPS_1H_STIM_BMDM_UP | TRPC4AP PFKFB3 VPS35L HRAS RIPOR1 PLXNA1 MRC1 PPP2R5E KLHL12 ZNF292 PCNT | 2.46e-06 | 200 | 239 | 11 | M5815 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | BDP1 TTC9B DSCAML1 TERF2IP NELL1 PPARGC1A DNAJC12 LRRC7 GOLGA7B PLXNA1 PDZRN4 TRHDE RALGDS MBLAC2 SLC4A8 LAMA3 LAMA5 GRID1 OCRL ARHGAP35 GRM3 GRM7 FRY TRIM9 B3GAT1 HYDIN EPB41L1 | 3.50e-06 | 1106 | 239 | 27 | M39071 |
| Coexpression | MURARO_PANCREAS_BETA_CELL | USP9X TERF2IP PTPN3 MYO3A SCAPER DNAJC12 OTULINL WDR17 HECTD1 DPYSL2 SLC4A7 PPM1E ARHGAP35 BTBD3 LMO2 TRIM9 KLHL12 EXOC2 PDZRN3 UNC80 EPB41L1 ZNF292 SORL1 NIN | 6.69e-06 | 946 | 239 | 24 | M39169 |
| Coexpression | GSE45365_BCELL_VS_CD8_TCELL_UP | 1.04e-05 | 190 | 239 | 10 | M9991 | |
| Coexpression | CUI_TCF21_TARGETS_2_DN | MYO6 USP9X ATP8B1 PFKFB3 JADE1 GVINP1 RIPOR1 DPYSL2 RRAS2 MBLAC2 DNAJB4 PELI2 GRM7 BTBD3 FRY IFRD1 LMO2 CD47 MYOM2 LRBA PALLD PLCE1 | 1.30e-05 | 854 | 239 | 22 | M1533 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HSERT | ABHD17A TTC9B LMTK3 NELL1 TRPV2 DNAJC12 KIT GOLGA7B RALGDS SLC4A8 GRM7 GRM8 FRY CD47 EPB41L1 | 1.84e-05 | 450 | 239 | 15 | M39072 |
| Coexpression | FAN_EMBRYONIC_CTX_EX_4_EXCITATORY_NEURON | 2.29e-05 | 166 | 239 | 9 | M39026 | |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | BDP1 ABHD17A HLA-A USP9X JADE1 ERBIN TERF2IP PTK2B PTPRA GVINP1 TRPV2 PDS5A YWHAQ ASCC3 KIT UBR2 RALGDS SLC4A7 SPG11 PSTPIP1 ARHGAP35 PPM1B PPP2R5E PLEKHO2 MAP4K1 CD47 LRBA ZNF292 SORL1 NIN | 4.18e-05 | 1492 | 239 | 30 | M40023 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | USP9X ATP8B1 ME2 PTPRA PSME4 PDS5A ASCC3 CAP2 FBXW11 UBR2 RRAS2 SLC4A7 SPG11 ARHGAP35 PPM1B NBAS IFRD1 PPP2R5E ZNF292 PCNT PLCE1 | 4.20e-05 | 856 | 239 | 21 | M4500 |
| Coexpression | HASLINGER_B_CLL_WITH_17P13_DELETION | 4.33e-05 | 22 | 239 | 4 | M3256 | |
| Coexpression | CUI_TCF21_TARGETS_2_DN | MYO6 USP9X ATP8B1 PFKFB3 JADE1 RIPOR1 DPYSL2 RRAS2 MBLAC2 DNAJB4 PELI2 GRM7 BTBD3 FRY IFRD1 LMO2 CD47 MYOM2 LRBA PALLD PLCE1 | 7.07e-05 | 888 | 239 | 21 | MM1018 |
| Coexpression | RADAEVA_RESPONSE_TO_IFNA1_DN | 8.57e-05 | 10 | 239 | 3 | M19208 | |
| Coexpression | GSE360_CTRL_VS_M_TUBERCULOSIS_MAC_UP | 9.04e-05 | 198 | 239 | 9 | M5170 | |
| Coexpression | GSE16385_IFNG_TNF_VS_UNSTIM_MACROPHAGE_ROSIGLITAZONE_TREATED_DN | 9.76e-05 | 200 | 239 | 9 | M8032 | |
| Coexpression | GSE16385_ROSIGLITAZONE_IL4_VS_IFNG_TNF_STIM_MACROPHAGE_UP | 9.76e-05 | 200 | 239 | 9 | M8030 | |
| Coexpression | GSE9650_EXHAUSTED_VS_MEMORY_CD8_TCELL_UP | 9.76e-05 | 200 | 239 | 9 | M5838 | |
| Coexpression | GSE41978_ID2_KO_VS_BIM_KO_KLRG1_LOW_EFFECTOR_CD8_TCELL_DN | 9.76e-05 | 200 | 239 | 9 | M9563 | |
| Coexpression | GSE3039_CD4_TCELL_VS_ALPHAALPHA_CD8_TCELL_UP | 9.76e-05 | 200 | 239 | 9 | M6456 | |
| Coexpression | GSE360_L_DONOVANI_VS_L_MAJOR_MAC_UP | 9.76e-05 | 200 | 239 | 9 | M5231 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HDA1 | TTC9B LMTK3 TERF2IP PTPN3 SCAPER ATP11C LRRC7 GOLGA7B PDZRN4 TRHDE RALGDS SLC4A8 OCRL GRM8 FRY EPB41L1 | 1.01e-04 | 584 | 239 | 16 | M39068 |
| Coexpression | NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN | SPTBN1 ATP8B1 PTP4A1 RAB30 HSPA6 GAREM1 WDR72 ENOSF1 RALGDS SPG11 BTBD3 LMO2 EIF4A1 FZD10 HAS3 ZNF292 SORL1 | 1.04e-04 | 648 | 239 | 17 | M14371 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | ABCA12 ADGRV1 DSCAML1 PPARGC1A PTPRD TRHDE DNAH10 GRID1 ODAD2 PKHD1L1 MYOM2 PLCH1 HYDIN UNC80 PLCE1 | 8.77e-14 | 184 | 239 | 15 | 2cbed6462fea2622871bb7e49b0df3d984239281 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | ABCA12 ADGRV1 DSCAML1 PPARGC1A PTPRD TRHDE DNAH10 GRID1 ODAD2 PKHD1L1 MYOM2 PLCH1 HYDIN UNC80 PLCE1 | 8.77e-14 | 184 | 239 | 15 | 2b19a8c5f823e00812908b23e66bb4e563278aff |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | ABCA12 ADGRV1 DSCAML1 PPARGC1A PTPRD TRHDE DNAH10 GRID1 ODAD2 PKHD1L1 MYOM2 PLCH1 HYDIN UNC80 PLCE1 | 8.77e-14 | 184 | 239 | 15 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | ABCA12 ADGRV1 DSCAML1 TRPM8 WDR17 PDZRN4 TRHDE DNAH10 ODAD2 PKHD1L1 HYDIN UNC80 | 7.37e-11 | 160 | 239 | 12 | c381ec6be8cf887861cc18f831a20db42f953fe1 |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | ABCA12 ADGRV1 DSCAML1 TRPM8 WDR17 PDZRN4 TRHDE DNAH10 ODAD2 PKHD1L1 HYDIN UNC80 | 7.37e-11 | 160 | 239 | 12 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | MYO6 PPARGC1A PTPN3 GAREM1 WDR72 TRHDE ENOSF1 CUBN ARHGEF10L TRPV4 LRBA EPB41L1 | 6.46e-10 | 193 | 239 | 12 | 82e8a4c40299ffcdfd5a0da711bb9de6fb8a2eaa |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW19-Neuronal-Interneuron|GW19 / Sample Type, Dataset, Time_group, and Cell type. | RYR1 NELL1 DNMT3A PDZRN4 TRHDE ENOSF1 CUBN GDPGP1 PDZRN3 UNC80 | 1.12e-09 | 121 | 239 | 10 | b2d571f571133c281d72584fe925cebbd2317829 |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | MYO6 PPARGC1A PTPN3 GAREM1 WDR72 TRHDE ENOSF1 CUBN ARHGEF10L LRBA EPB41L1 | 8.38e-09 | 193 | 239 | 11 | 3866667dd221612589ae50f5c52f73a183a49ce6 |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | MYO6 DSCAML1 PPARGC1A PTPN3 GAREM1 WDR72 TRHDE VEPH1 ARHGEF10L LRBA EPB41L1 | 9.33e-09 | 195 | 239 | 11 | 6477e6e7be5bd8eb99119a12ae16334ccddecd43 |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | ABCA12 ADGRV1 TRPM8 DNAH10 VEPH1 CUBN PKHD1L1 PLCH1 HYDIN UNC80 | 2.83e-08 | 169 | 239 | 10 | 12bdc709bc000d7f9061ecd9fbd57233eaacb7e2 |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_proliferating-epi_proliferating2_(13)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 9.42e-08 | 192 | 239 | 10 | 25378b5e4b0cea8415ff125783511fc25a56fc00 | |
| ToppCell | COVID-19-Heart-CM_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | PPARGC1A CAP2 RRAS2 MYOM3 WDPCP FRY MYOM2 CFAP61 PALLD PDZRN3 | 9.89e-08 | 193 | 239 | 10 | dd5378a1ef8eb0eda9a3aae62f3c2f3a1402bda0 |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | PPARGC1A PTPN3 GAREM1 WDR72 TRHDE VEPH1 ARHGEF10L LRBA HYDIN EPB41L1 | 1.04e-07 | 194 | 239 | 10 | 93c68c31e39fa44c1d05d7d4997f4f086da4e738 |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | MYO6 PFKFB3 PTPN3 WDR72 SLC4A7 VEPH1 ARHGEF10L LRBA EPB41L1 SORL1 | 1.14e-07 | 196 | 239 | 10 | c7136b1c83bcf907eec3b02b151fa061298b6672 |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | MYO6 PPARGC1A PTPN3 WDR72 TRHDE VEPH1 ARHGEF10L LRBA HYDIN EPB41L1 | 1.14e-07 | 196 | 239 | 10 | 6ce74aa3f0ce3ca284b67e5a4660ffd2cc9611e0 |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.26e-07 | 198 | 239 | 10 | a7e5de81eb7d3d23812c179a001adbaab1506596 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Macroglial-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | MYO6 HAPLN2 ERBIN PTP4A1 PTPRD PLXNB3 RALGDS GRM3 NRBP2 KNDC1 | 1.38e-07 | 200 | 239 | 10 | 0e85c90719d9ec51a566e230c9dd2909d8df1f52 |
| ToppCell | droplet-Lung-3m-Hematologic-myeloid-plasmacytoid_dendritic_cell-plasmacytoid_dendritic|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.68e-07 | 164 | 239 | 9 | cfe07a1ebed8aecb08d0476db71fe314998d54aa | |
| ToppCell | droplet-Lung-3m-Hematologic-myeloid-plasmacytoid_dendritic_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.68e-07 | 164 | 239 | 9 | 6d331e74efecb4733d87653f86cd67247be05025 | |
| ToppCell | BAL-Severe-Myeloid-cDC-cDC-cDC_4|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.29e-07 | 168 | 239 | 9 | d60f7cd8269f373827f49c7785002cb38e4570a9 | |
| ToppCell | BAL-Severe-Myeloid-cDC-cDC-cDC_4|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.46e-07 | 169 | 239 | 9 | ccd98f9005aa0a88bd49f153be4e7200cc3dd0ac | |
| ToppCell | facs-Heart-LA-24m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.11e-07 | 177 | 239 | 9 | 32fecefba1a55e1f418c9a055236fa11175c692d | |
| ToppCell | facs-Heart-LA-24m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.11e-07 | 177 | 239 | 9 | 1b153fbfe1323dc589de4af73a52149ea5ce6763 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.75e-07 | 183 | 239 | 9 | 31ab55d5f3639f5964541d5eae23044dbda3356e | |
| ToppCell | Children_(3_yrs)-Epithelial-ciliated_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.07e-07 | 184 | 239 | 9 | 5daff849625f2f41d56615569c0ed59cd733b34c | |
| ToppCell | Adult-Epithelial-ciliated_cell-D175|Adult / Lineage, Cell type, age group and donor | DSCAML1 LRRIQ1 DNAH10 PPM1E ODAD2 SLC9C2 DNAH12 CFAP61 HYDIN | 7.39e-07 | 185 | 239 | 9 | 30f4980dee6cd5959655f8d74049f3bfb5312611 |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | ACACB NELL1 PPARGC1A SLC4A7 SLC4A8 TBC1D30 PPM1E CLDN16 LRBA | 8.09e-07 | 187 | 239 | 9 | b93cf4dfe8ffb89348ee7bccc9f284189f7240a2 |
| ToppCell | LV-04._Ventricular_Cardiomyocyte_I|World / Chamber and Cluster_Paper | ACACB PPARGC1A CAP2 MYOM3 IL1RAPL1 MYOM2 CFAP61 RNF207 PDZRN3 | 8.46e-07 | 188 | 239 | 9 | 0758b474457efa36488e0195f7357100f4b6a090 |
| ToppCell | Children_(3_yrs)-Epithelial-ciliated_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.46e-07 | 188 | 239 | 9 | 2b6dfc88be9ded7b88da9fe78a9cd9f9b3af8af3 | |
| ToppCell | facs-Marrow-B-cells-24m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.73e-07 | 139 | 239 | 8 | 2a54627947f8c6597c041f4785f8a4e52d0edfba | |
| ToppCell | facs-Marrow-B-cells-24m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.73e-07 | 139 | 239 | 8 | 27dd36f5ef03fa97f0fdb19fbd259cb60e7962b3 | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | PPARGC1A PSME4 CAP2 GAREM1 IL1RAPL1 MYOM2 CFAP61 PALLD PDZRN3 | 8.84e-07 | 189 | 239 | 9 | 0a82931b5f6c0a6427ca3edd5e2235ac49099d40 |
| ToppCell | LV-06._Ventricular_Cardiomyocyte_II|World / Chamber and Cluster_Paper | ACACB PPARGC1A MYOM3 IL1RAPL1 MYOM2 CFAP61 RNF207 PALLD PDZRN3 | 9.23e-07 | 190 | 239 | 9 | de5ef606a002f85c2e0e3a36c1f259d0b85a76ff |
| ToppCell | LV-04._Ventricular_Cardiomyocyte_I|LV / Chamber and Cluster_Paper | 1.01e-06 | 192 | 239 | 9 | ad19e2c1d36a0566c9b12ced10db78f4781c8ea6 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-24m-Macroglial-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.03e-06 | 142 | 239 | 8 | 67d4ff3483ae34f77c3325aa0fbd3462ca19ade4 | |
| ToppCell | wk_08-11-Hematologic-Meg-ery-Definitive_erythroblast|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 1.05e-06 | 193 | 239 | 9 | be75abfdf5301cf33df8ee9ed92504d44fdf19a6 | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_1|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.08e-06 | 143 | 239 | 8 | 5fb5a4ea93e5cce55d427e3b4a50a979504fad3c | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.10e-06 | 194 | 239 | 9 | 7002937e8903e037332a215d00fbc7c7843b33f2 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | PPARGC1A PTPN3 WDR72 TRHDE SLC4A7 VEPH1 ARHGEF10L LRBA EPB41L1 | 1.20e-06 | 196 | 239 | 9 | eea66711a16134f86e6c533a5a837ff2e0d7ca7f |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_ciliated-Ciliated|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.41e-06 | 200 | 239 | 9 | 926a7ea94b5908aebf103893ea83ce9d25285b65 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Macroglial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.41e-06 | 200 | 239 | 9 | 56f1f007ba8c9188a4b10e52744f1e50dc0f155a | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.41e-06 | 200 | 239 | 9 | f0c338877e39226a90c4effe12f6501d33542a73 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_ciliated|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.41e-06 | 200 | 239 | 9 | 06ce6e03498ba38ef6a06eaf2731e3b2eeda59eb | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.41e-06 | 200 | 239 | 9 | fc28f71ca1cd0fdae66009ae5afe175d22f2bd8c | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Macroglial-oligodendrocyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.41e-06 | 200 | 239 | 9 | e5b4821fff40566c4a7dc3f74a14e27eb06b165d | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway-Ciliated_cells|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.98e-06 | 155 | 239 | 8 | 5f1e2195a6b831e1b636f5cc3a282ca423721822 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway-Ciliated_cells-Ciliated|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.98e-06 | 155 | 239 | 8 | 0944429459f642a1bcc56edc1ec28aaecde3e2dc | |
| ToppCell | LPS-antiTNF-Myeloid-Dendritic_cells-mDC|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.61e-06 | 168 | 239 | 8 | 2dca1c4a33b6da9357fa3b2a523af19baab1c21c | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.77e-06 | 169 | 239 | 8 | fba841664939c771881ba97f14ef1df6635c04ff | |
| ToppCell | LPS-antiTNF-Myeloid-Dendritic_cells|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.94e-06 | 170 | 239 | 8 | 3cbeea6bfa500928c413b1c6129f6dedc769cd1e | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.12e-06 | 171 | 239 | 8 | 4ede831aed364cb5271f49a8b09bb6d0452f9b35 | |
| ToppCell | 3'-Distal_airway-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.49e-06 | 173 | 239 | 8 | c3762655caa79ac4879876f470d32578a3c93b01 | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Th-Inhibitory_Neuron.Th.Nefl_(Neurofilament_state)|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 4.66e-06 | 46 | 239 | 5 | 37ea73d291e35b6865bd3ea4857275a6e5b299d1 | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Th-Inhibitory_Neuron.Th.Nefl_(Neurofilament_state)-|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 4.66e-06 | 46 | 239 | 5 | 69e9c8cbae3d15bd0823b8c6e48a9d2b9815296b | |
| ToppCell | LPS-IL1RA-Myeloid-Dendritic_cells|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.09e-06 | 176 | 239 | 8 | f3bbe8c1a8d132705eac360cf531261271d84588 | |
| ToppCell | facs-Trachea-3m-Epithelial-airway_epithelial-tracheobronchial_ciliated_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.31e-06 | 177 | 239 | 8 | 12a52a12a87a31e501ced611f46a90d172ca7e35 | |
| ToppCell | facs-Trachea-3m-Epithelial-airway_epithelial-tracheobronchial_ciliated_cell-ciliated_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.31e-06 | 177 | 239 | 8 | 3cfde67b93f3986312f5e74e42504214d966e7dc | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.77e-06 | 179 | 239 | 8 | 8da6863edc756540bb097cc7221c1408640d9bb4 | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.77e-06 | 179 | 239 | 8 | f39c13c99a07d009cc677e363ffe089089c64916 | |
| ToppCell | facs-Trachea-nan-3m-Epithelial-ciliated_columnar_cell_of_tracheobronchial_tree|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.01e-06 | 180 | 239 | 8 | cf6e9f757afeb342c5023f6e6152a1b4d0d164b4 | |
| ToppCell | RV|World / Chamber and Cluster_Paper | 6.26e-06 | 181 | 239 | 8 | bbe1e6e59d8889bd37d6e8303116cbdcafca7236 | |
| ToppCell | wk_15-18-Hematologic-Meg-ery-Definitive_erythroblast|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 6.51e-06 | 182 | 239 | 8 | 93841f730ca1a735eaaf5f2ccbe5c45ab0e029d1 | |
| ToppCell | Control-Epithelial_cells-Airway_ciliated|Control / group, cell type (main and fine annotations) | 6.51e-06 | 182 | 239 | 8 | fb725d10d9ed25dfc6d5bb69cfef78513f7d3e8f | |
| ToppCell | wk_20-22-Hematologic-Meg-ery-Definitive_erythroblast|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 6.51e-06 | 182 | 239 | 8 | 0c77ef4556c1d1512ebe9077df858b28f9e38dd5 | |
| ToppCell | COVID-19-kidney-Distal_Epi_Doublet_(PCT)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.51e-06 | 182 | 239 | 8 | 9d67717a6e13bcb54c1297a3e4e3abf4e51628a3 | |
| ToppCell | Adult-Epithelial-ciliated_cell-D122|Adult / Lineage, Cell type, age group and donor | 6.51e-06 | 182 | 239 | 8 | 7ded554a4b441e6496db673ba206c0d76ccad7d9 | |
| ToppCell | LPS-IL1RA+antiTNF-Myeloid-Dendritic_cells-mDC|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.33e-06 | 132 | 239 | 7 | f8e2ba53063007d7507f1837ad669b0e4333cd23 | |
| ToppCell | Control-Epithelial_alveolar-AT_2-Differentiating_AT2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.34e-06 | 185 | 239 | 8 | 0d2add28ac1f4fa6de7699be009bf8391badaf4c | |
| ToppCell | COVID-19-Epithelial_cells-Airway_ciliated|COVID-19 / group, cell type (main and fine annotations) | 7.34e-06 | 185 | 239 | 8 | 18a40f0a338aa398d81384b5159fb80ce8a2020c | |
| ToppCell | 368C-Epithelial_cells-Epithelial-G_(Club-Clara_cells)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 7.64e-06 | 186 | 239 | 8 | 77bebf576eb9b96ecb4fefb8a82a31aaaa917fc0 | |
| ToppCell | P28-Epithelial-airway_epithelial_cell-club_cell|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 7.64e-06 | 186 | 239 | 8 | a26811481668fa25c48a064a56c198685693ad8d | |
| ToppCell | P28-Epithelial-airway_epithelial_cell|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 7.64e-06 | 186 | 239 | 8 | df80f101954b8ec6ccdb03e702de22e70b65181f | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.64e-06 | 186 | 239 | 8 | f28d72b47624b69a580b4429e2be560a26898591 | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^high_distal_(10)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 7.64e-06 | 186 | 239 | 8 | bb0bfe9a015151be08a6ffc5d82896d0556d76de | |
| ToppCell | 368C-Epithelial_cells-Epithelial-G_(Club-Clara_cells)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 7.64e-06 | 186 | 239 | 8 | 13bc41c60fd628af31899a5e8b480e06cc4781be | |
| ToppCell | facs-Lung-EPCAM-18m-Epithelial-Ciliated_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.94e-06 | 187 | 239 | 8 | 888856cde7a69ea2f14d590597e25b1af6383c51 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.94e-06 | 187 | 239 | 8 | 52b5b38bef3cc06487cf42c6fb22fb33f0c7ce2b | |
| ToppCell | COPD-Epithelial-Ciliated|COPD / Disease state, Lineage and Cell class | 7.94e-06 | 187 | 239 | 8 | f0fd0792f6926f705d175f6e6fd480f12c7a3bd4 | |
| ToppCell | COVID-19-kidney-Mito-rich_Distal|kidney / Disease (COVID-19 only), tissue and cell type | 7.94e-06 | 187 | 239 | 8 | 2ce8038d9d1302e850c1bb536e755598f77ba4b9 | |
| ToppCell | facs-Lung-EPCAM-18m-Epithelial-ciliated_columnar_cell_of_tracheobronchial_tree|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.94e-06 | 187 | 239 | 8 | 051b8c07d7489ce7576f6c57ce7008767ef76869 | |
| ToppCell | COVID-19-kidney-DCT|COVID-19 / Disease (COVID-19 only), tissue and cell type | 8.26e-06 | 188 | 239 | 8 | 1d56cd409793f05cca20757ab26e91f1a1ee67b5 | |
| ToppCell | COVID-19-kidney-CD-PC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 8.26e-06 | 188 | 239 | 8 | 8f9996c3f3b27efaaae8960a66af77412de9c7ef | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.58e-06 | 189 | 239 | 8 | de51fbd6fdb24fc4549393cf41a020005444b2aa | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_alveolar-distal-epi_SFTPC^high_distal_(9)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 8.58e-06 | 189 | 239 | 8 | 5d9da836ce4308b8458bb3be3871a0aca734b6cd | |
| ToppCell | RV-04._Ventricular_Cardiomyocyte_I|RV / Chamber and Cluster_Paper | 8.58e-06 | 189 | 239 | 8 | 9c1debd65c13d63fd4f3158917d621b44b714c26 | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|World / Chamber and Cluster_Paper | 8.58e-06 | 189 | 239 | 8 | 5e80c47f63980904c4c1ff02c201b67b456a0974 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 8.92e-06 | 190 | 239 | 8 | 8aea807a2bcf0b653b4de6202b6ecb0f0683cc2e | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-RG-RG-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.92e-06 | 190 | 239 | 8 | 7a560d046aeff979cdf543c519e4e51280f5e232 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.92e-06 | 190 | 239 | 8 | 45df8fee00f8949937863159d7aa042e72748d9b | |
| ToppCell | COPD-Myeloid-Macrophage_Alveolar|Myeloid / Disease state, Lineage and Cell class | 8.92e-06 | 190 | 239 | 8 | 9fc763d65470ba8858b973689c4d4358faab7dd3 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Alv_Gen_Intermediate|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.92e-06 | 190 | 239 | 8 | 106ea0bb7b99c697ffc5443d72343df2484250c7 | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|RV / Chamber and Cluster_Paper | 8.92e-06 | 190 | 239 | 8 | 93c3188dfeb0b2f9889f8ae9b9c1f2f34129c99b | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.92e-06 | 190 | 239 | 8 | 1bbbf0ce222e51f9fd2daca0c18d3965fd4efd31 | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|RV / Chamber and Cluster_Paper | 8.92e-06 | 190 | 239 | 8 | fe8e78922c8ae928ef9a80bffd67868d5a87a091 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 9.27e-06 | 191 | 239 | 8 | 34cc997e4e5c727495f321e6807a84aa124da486 | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_proliferating-epi_proliferating2_(13)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 9.27e-06 | 191 | 239 | 8 | 39220f4a345e328f7fa4fd462a0abeea821b3e02 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.27e-06 | 191 | 239 | 8 | 963f4f2e852bbb4faf070aafb0d368297abacd3b | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_proliferating-epi_proliferating3_(5)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 9.63e-06 | 192 | 239 | 8 | d3634574b2e8d2ded6446969361b70761b331aea | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.63e-06 | 192 | 239 | 8 | 3d0cb19f037f604253d7d728689aeaa94251e92b | |
| ToppCell | IPF-Epithelial-Ciliated|World / Disease state, Lineage and Cell class | 9.63e-06 | 192 | 239 | 8 | d903bbd6c18e29e2c4cdedeb3fea1fd5ad7baa11 | |
| Drug | cis-MCG-I | 7.89e-07 | 8 | 238 | 4 | CID003035584 | |
| Drug | alpha-methyl-4-carboxyphenylglycine | 8.84e-07 | 32 | 238 | 6 | CID000001222 | |
| Drug | mM PEP | 1.41e-06 | 9 | 238 | 4 | CID005311462 | |
| Drug | AC1N21PP | 1.41e-06 | 9 | 238 | 4 | CID004014619 | |
| Drug | 1,3-cyclopentanedicarboxylic acid | 1.41e-06 | 9 | 238 | 4 | CID000107216 | |
| Drug | 3,4-dihydroxyphenylglycine | 2.12e-06 | 21 | 238 | 5 | CID000027915 | |
| Drug | NS-105 | 2.33e-06 | 10 | 238 | 4 | CID000198695 | |
| Drug | 4CPG | 2.56e-06 | 38 | 238 | 6 | CID000005115 | |
| Drug | cyclobutylene AP5 | 3.63e-06 | 11 | 238 | 4 | CID000126582 | |
| Drug | L 744832 | 4.48e-06 | 4 | 238 | 3 | ctd:C096898 | |
| Drug | Mspg | 7.73e-06 | 13 | 238 | 4 | CID003964410 | |
| Drug | MSOPPE | 7.73e-06 | 13 | 238 | 4 | CID005311463 | |
| Drug | AC1NSKBB | 7.73e-06 | 13 | 238 | 4 | CID005311256 | |
| Drug | Talampicillin hydrochloride [39878-70-1]; Down 200; 7.8uM; PC3; HT_HG-U133A | ACACB SPTBN1 RNF40 SNX16 VPS35L SMG9 FBXW11 ATG2B DNAJB4 KDM4A WDTC1 | 8.45e-06 | 199 | 238 | 11 | 7254_DN |
| Drug | C-PP | 9.66e-06 | 28 | 238 | 5 | CID000001228 | |
| Drug | MTPG | 1.07e-05 | 14 | 238 | 4 | CID005311456 | |
| Drug | 2-methyl-6-styrylpyridine | 1.07e-05 | 14 | 238 | 4 | CID000235382 | |
| Drug | ethylglutamate | 1.92e-05 | 16 | 238 | 4 | CID000014241 | |
| Drug | 2-PMPA | 1.92e-05 | 16 | 238 | 4 | CID010130754 | |
| Drug | 1-aminoindan-1,5-dicarboxylic acid | 2.24e-05 | 33 | 238 | 5 | CID000002071 | |
| Drug | 2-phenylglycine | 2.31e-05 | 55 | 238 | 6 | CID000003866 | |
| Drug | 3HPG | 2.49e-05 | 17 | 238 | 4 | CID000001217 | |
| Drug | Minocycline hydrochloride [13614-98-7]; Up 200; 8uM; HL60; HT_HG-U133A | 3.17e-05 | 189 | 238 | 10 | 2405_UP | |
| Drug | acromelic acid A | 3.17e-05 | 18 | 238 | 4 | CID000108086 | |
| Drug | Cefadroxil [50370-12-2]; Down 200; 11uM; MCF7; HT_HG-U133A | HLCS WIZ OTULINL PLXNA1 DNMT3A TRIOBP KLHL22 PLEKHO2 CD47 KDM8 | 3.79e-05 | 193 | 238 | 10 | 4161_DN |
| Drug | Norfloxacin [70458-96-7]; Down 200; 12.6uM; MCF7; HT_HG-U133A | HLCS WIZ MRC2 RAB30 SCAPER DNMT3A KRAS TBC1D30 ARHGAP35 ARHGEF10L | 3.79e-05 | 193 | 238 | 10 | 5985_DN |
| Drug | azetidine-2,4-dicarboxylic acid | 3.83e-05 | 7 | 238 | 3 | CID000005370 | |
| Drug | benzyloxyaspartate | 3.97e-05 | 37 | 238 | 5 | CID004133412 | |
| Drug | aminocyclopentane | 3.99e-05 | 19 | 238 | 4 | CID000002906 | |
| Drug | Meticrane [1084-65-7]; Down 200; 14.6uM; PC3; HT_HG-U133A | ECHDC1 ATP8B1 SNX16 PSME4 AP1G2 DMBT1 PLEC SLC4A7 TTPAL CCNE2 | 4.51e-05 | 197 | 238 | 10 | 1792_DN |
| Drug | L-BMAA | 4.53e-05 | 38 | 238 | 5 | CID000028558 | |
| Drug | Gallamine triethiodide [65-29-2]; Up 200; 4.4uM; HL60; HG-U133A | 4.91e-05 | 199 | 238 | 10 | 1375_UP | |
| Drug | 4-carboxy-3-hydroxyphenylglycine | 4.95e-05 | 20 | 238 | 4 | CID000001297 | |
| Drug | Acetopromazine maleate salt [3598-37-6]; Up 200; 9uM; HL60; HG-U133A | HLCS GCDH RNF40 WIZ RAB30 SCAPER DMBT1 ARHGAP35 TRIM9 TRIM62 | 5.12e-05 | 200 | 238 | 10 | 1777_UP |
| Drug | Sertaconazole nitrate [99592-39-9]; Up 200; 8uM; HL60; HT_HG-U133A | 5.12e-05 | 200 | 238 | 10 | 6128_UP | |
| Drug | Pseudopelletierine hydrochloride [6164-62-1]; Down 200; 21uM; PC3; HT_HG-U133A | ACACB SPTBN1 DHX38 SNX16 PDS5A RIPOR1 KRAS NBAS EXOSC7 EPB41L1 | 5.12e-05 | 200 | 238 | 10 | 5828_DN |
| Drug | (R)-(+)-Atenolol [56715-13-0]; Down 200; 15uM; MCF7; HT_HG-U133A | DHX38 ATP8B1 RRBP1 MRC2 PLEC RALGDS LAMA3 ARHGAP35 AKAP8L PLCH1 | 5.12e-05 | 200 | 238 | 10 | 4841_DN |
| Drug | DETC-MeSO | 5.16e-05 | 39 | 238 | 5 | CID003035711 | |
| Drug | CC-I | 5.53e-05 | 64 | 238 | 6 | CID000448159 | |
| Drug | 5224221; Up 200; 12uM; MCF7; HT_HG-U133A_EA | 6.54e-05 | 166 | 238 | 9 | 956_UP | |
| Drug | AC1NNRU4 | 6.60e-05 | 41 | 238 | 5 | CID005126051 | |
| Drug | 1,3-butadiene | 6.60e-05 | 41 | 238 | 5 | ctd:C031763 | |
| Drug | rolipram | 7.70e-05 | 253 | 238 | 11 | CID000005092 | |
| Drug | LY341495 | 8.33e-05 | 43 | 238 | 5 | CID006324636 | |
| Drug | Joro spider toxin | 8.33e-05 | 43 | 238 | 5 | CID000119582 | |
| Drug | MSOP | 8.82e-05 | 23 | 238 | 4 | CID003964633 | |
| Drug | YM90K | 8.82e-05 | 23 | 238 | 4 | CID005486547 | |
| Drug | Biotin | 9.04e-05 | 9 | 238 | 3 | DB00121 | |
| Drug | AC1L32OA | 9.04e-05 | 9 | 238 | 3 | CID000107745 | |
| Drug | felbamate | 9.19e-05 | 70 | 238 | 6 | CID000003331 | |
| Drug | 17-AAG; Up 200; 1uM; MCF7; HT_HG-U133A_EA | 9.39e-05 | 174 | 238 | 9 | 1063_UP | |
| Drug | CGP 39653 | 1.05e-04 | 24 | 238 | 4 | CID006437837 | |
| Drug | RS)-2-chloro-5-hydroxyphenylglycine | 1.05e-04 | 24 | 238 | 4 | CID003645780 | |
| Drug | isoprene | 1.09e-04 | 2 | 238 | 2 | ctd:C005059 | |
| Drug | AC1L97TH | 1.09e-04 | 2 | 238 | 2 | CID000439677 | |
| Drug | N-Formyl-Met-Val | 1.09e-04 | 2 | 238 | 2 | CID000100136 | |
| Drug | streptovarone | 1.09e-04 | 2 | 238 | 2 | CID006445223 | |
| Drug | cysteine sulfinic acid | 1.16e-04 | 46 | 238 | 5 | CID000000109 | |
| Drug | L-quisqualic acid | 1.22e-04 | 180 | 238 | 9 | CID000001209 | |
| Drug | gavestinel | 1.24e-04 | 25 | 238 | 4 | CID006450546 | |
| Drug | phencyclidine | 1.27e-04 | 181 | 238 | 9 | CID000006468 | |
| Drug | AC1NRCO0 | 1.28e-04 | 10 | 238 | 3 | CID005289100 | |
| Drug | bromophenol blue | 1.45e-04 | 26 | 238 | 4 | CID000008272 | |
| Drug | AC1NQH9B | 1.45e-04 | 26 | 238 | 4 | CID005221504 | |
| Drug | methylenecyclopropylglycine | 1.57e-04 | 49 | 238 | 5 | CID000441452 | |
| Disease | RASopathy (implicated_via_orthology) | 4.71e-07 | 9 | 234 | 4 | DOID:0080690 (implicated_via_orthology) | |
| Disease | Verrucous epidermal nevus | 4.92e-07 | 3 | 234 | 3 | C0362030 | |
| Disease | Nevus Sebaceus of Jadassohn | 4.92e-07 | 3 | 234 | 3 | C4552097 | |
| Disease | Organoid Nevus Phakomatosis | 4.92e-07 | 3 | 234 | 3 | C0265329 | |
| Disease | Linear nevus sebaceous syndrome | 4.92e-07 | 3 | 234 | 3 | cv:C4552097 | |
| Disease | Nevus sebaceous | 4.92e-07 | 3 | 234 | 3 | C3854181 | |
| Disease | Inflammatory linear verrucous epidermal nevus | 4.92e-07 | 3 | 234 | 3 | C0473574 | |
| Disease | SCHIMMELPENNING-FEUERSTEIN-MIMS SYNDROME | 4.92e-07 | 3 | 234 | 3 | 163200 | |
| Disease | linear nevus sebaceous syndrome (is_implicated_in) | 4.92e-07 | 3 | 234 | 3 | DOID:0111530 (is_implicated_in) | |
| Disease | Noonan syndrome 3 (implicated_via_orthology) | 4.92e-07 | 3 | 234 | 3 | DOID:0060581 (implicated_via_orthology) | |
| Disease | Linear Verrucous Epidermal Nevus | 4.92e-07 | 3 | 234 | 3 | C3179502 | |
| Disease | cervical cancer (implicated_via_orthology) | 4.92e-07 | 3 | 234 | 3 | DOID:4362 (implicated_via_orthology) | |
| Disease | NEVUS, EPIDERMAL (disorder) | 4.87e-06 | 5 | 234 | 3 | C0334082 | |
| Disease | Follicular thyroid carcinoma | 4.87e-06 | 5 | 234 | 3 | C0206682 | |
| Disease | Hemimegalencephaly | 9.68e-06 | 6 | 234 | 3 | C0431391 | |
| Disease | seminoma (is_implicated_in) | 9.68e-06 | 6 | 234 | 3 | DOID:4440 (is_implicated_in) | |
| Disease | Juvenile Myelomonocytic Leukemia | 1.36e-05 | 19 | 234 | 4 | C0349639 | |
| Disease | serum albumin measurement | SKIDA1 ADGRV1 PTPN3 AFP RTL9 PLEC HSPA6 WDR72 KRAS MRC1 NRAS FRY EIF4A1 EXOC2 EIF3J PCNT | 2.30e-05 | 592 | 234 | 16 | EFO_0004535 |
| Disease | melanoma | 3.17e-05 | 248 | 234 | 10 | C0025202 | |
| Disease | Attention deficit hyperactivity disorder | 3.62e-05 | 24 | 234 | 4 | C1263846 | |
| Disease | Noonan Syndrome | 3.62e-05 | 24 | 234 | 4 | C0028326 | |
| Disease | Colorectal Carcinoma | ABCA12 DSCAML1 DNALI1 NELL1 PTPRD ATP11C PDZRN4 KRAS RALGDS DPYSL2 NRAS PPM1E GRID1 CUBN ARHGEF10L ZNF292 SORL1 | 5.06e-05 | 702 | 234 | 17 | C0009402 |
| Disease | RAS-ASSOCIATED AUTOIMMUNE LEUKOPROLIFERATIVE DISORDER | 6.26e-05 | 2 | 234 | 2 | 614470 | |
| Disease | Autoimmune lymphoproliferative syndrome type 4 | 6.26e-05 | 2 | 234 | 2 | cv:C2674723 | |
| Disease | Usher syndrome type 2C (implicated_via_orthology) | 6.26e-05 | 2 | 234 | 2 | DOID:0110839 (implicated_via_orthology) | |
| Disease | autoimmune lymphoproliferative syndrome type 4 (is_implicated_in) | 6.26e-05 | 2 | 234 | 2 | DOID:0110117 (is_implicated_in) | |
| Disease | MELANOCYTIC NEVUS SYNDROME, CONGENITAL | 6.26e-05 | 2 | 234 | 2 | 137550 | |
| Disease | Melanocytic nevus | 6.26e-05 | 2 | 234 | 2 | cv:C0027962 | |
| Disease | RAS-ASSOCIATED AUTOIMMUNE LEUKOPROLIFERATIVE DISORDER | 6.26e-05 | 2 | 234 | 2 | C2674723 | |
| Disease | large congenital melanocytic nevus (is_implicated_in) | 6.26e-05 | 2 | 234 | 2 | DOID:0111359 (is_implicated_in) | |
| Disease | Large congenital melanocytic nevus | 6.26e-05 | 2 | 234 | 2 | cv:C1842036 | |
| Disease | Intellectual Disability | KIFBP EIF4A3 ADSL SCAPER ASCC3 FBXW11 DNMT3A RALGDS FRY GTPBP2 TBC1D23 EPB41L1 ZNF292 | 6.52e-05 | 447 | 234 | 13 | C3714756 |
| Disease | Noonan Syndrome 1 | 7.75e-05 | 11 | 234 | 3 | C4551602 | |
| Disease | Turner Syndrome, Male | 7.75e-05 | 11 | 234 | 3 | C0041409 | |
| Disease | Female Pseudo-Turner Syndrome | 7.75e-05 | 11 | 234 | 3 | C1527404 | |
| Disease | kidney cancer (implicated_via_orthology) | 7.75e-05 | 11 | 234 | 3 | DOID:263 (implicated_via_orthology) | |
| Disease | GIANT PIGMENTED HAIRY NEVUS | 1.87e-04 | 3 | 234 | 2 | C1842036 | |
| Disease | Costello syndrome (implicated_via_orthology) | 1.87e-04 | 3 | 234 | 2 | DOID:0050469 (implicated_via_orthology) | |
| Disease | RASopathy | 2.09e-04 | 15 | 234 | 3 | cv:C5555857 | |
| Disease | heart disease (implicated_via_orthology) | 2.30e-04 | 38 | 234 | 4 | DOID:114 (implicated_via_orthology) | |
| Disease | migraine disorder, endometriosis | 2.91e-04 | 73 | 234 | 5 | EFO_0001065, MONDO_0005277 | |
| Disease | Acute myeloid leukemia | 3.08e-04 | 17 | 234 | 3 | cv:C0023467 | |
| Disease | LEUKEMIA, ACUTE MYELOID | 3.08e-04 | 17 | 234 | 3 | 601626 | |
| Disease | Alcoholic Intoxication, Chronic | 3.10e-04 | 268 | 234 | 9 | C0001973 | |
| Disease | Seminoma | 3.72e-04 | 4 | 234 | 2 | C0036631 | |
| Disease | NEVUS, EPIDERMAL | 3.72e-04 | 4 | 234 | 2 | 162900 | |
| Disease | Malignant neoplasm of penis | 3.72e-04 | 4 | 234 | 2 | C0153601 | |
| Disease | Penile Neoplasms | 3.72e-04 | 4 | 234 | 2 | C0030849 | |
| Disease | marginal zone B- and B1-cell-specific protein measurement | 3.72e-04 | 4 | 234 | 2 | EFO_0802730 | |
| Disease | Nevus, Keratinocytic, Nonepidermolytic | 3.72e-04 | 4 | 234 | 2 | C4011754 | |
| Disease | BLADDER CANCER | 3.72e-04 | 4 | 234 | 2 | 109800 | |
| Disease | Epidermal nevus | 3.72e-04 | 4 | 234 | 2 | cv:C0334082 | |
| Disease | Malignant tumor of urinary bladder | 3.72e-04 | 4 | 234 | 2 | cv:C0005684 | |
| Disease | Thymus Neoplasms | 3.72e-04 | 4 | 234 | 2 | C3714644 | |
| Disease | Thyroid cancer, nonmedullary, 2 | 3.72e-04 | 4 | 234 | 2 | cv:C4225426 | |
| Disease | Malignant tumor of cervix | 3.72e-04 | 4 | 234 | 2 | C0007847 | |
| Disease | epidermal nevus (is_implicated_in) | 3.72e-04 | 4 | 234 | 2 | DOID:0111162 (is_implicated_in) | |
| Disease | THYROID CANCER, NONMEDULLARY, 2 | 3.72e-04 | 4 | 234 | 2 | 188470 | |
| Disease | Noonan-Like Syndrome With Loose Anagen Hair | 4.34e-04 | 19 | 234 | 3 | C3501846 | |
| Disease | Noonan syndrome-like disorder with loose anagen hair | 4.34e-04 | 19 | 234 | 3 | C1843181 | |
| Disease | Cardio-facio-cutaneous syndrome | 4.34e-04 | 19 | 234 | 3 | C1275081 | |
| Disease | Costello syndrome (disorder) | 4.34e-04 | 19 | 234 | 3 | C0587248 | |
| Disease | leukemia (implicated_via_orthology) | 4.34e-04 | 19 | 234 | 3 | DOID:1240 (implicated_via_orthology) | |
| Disease | Nonsyndromic Deafness | 4.72e-04 | 81 | 234 | 5 | C3711374 | |
| Disease | Neuroblastoma | 5.26e-04 | 47 | 234 | 4 | C0027819 | |
| Disease | THYROID CANCER, NONMEDULLARY, 2 | 6.16e-04 | 5 | 234 | 2 | C4225426 | |
| Disease | Malignant neoplasm of thyroid | 6.16e-04 | 5 | 234 | 2 | C0007115 | |
| Disease | Cetuximab response | 6.16e-04 | 5 | 234 | 2 | cv:CN077967 | |
| Disease | Cervix carcinoma | 6.16e-04 | 5 | 234 | 2 | C0302592 | |
| Disease | Panitumumab response | 6.16e-04 | 5 | 234 | 2 | cv:CN077999 | |
| Disease | Attention Deficit Disorder | 6.78e-04 | 22 | 234 | 3 | C0041671 | |
| Disease | LEOPARD Syndrome | 6.78e-04 | 22 | 234 | 3 | C0175704 | |
| Disease | Minimal Brain Dysfunction | 6.78e-04 | 22 | 234 | 3 | C1321905 | |
| Disease | Nonsyndromic Hearing Loss and Deafness, Autosomal Recessive | 7.19e-04 | 51 | 234 | 4 | cv:CN043650 | |
| Disease | glycine measurement | 8.08e-04 | 137 | 234 | 6 | EFO_0009767 | |
| Disease | Profound Mental Retardation | 8.71e-04 | 139 | 234 | 6 | C0020796 | |
| Disease | Mental Retardation, Psychosocial | 8.71e-04 | 139 | 234 | 6 | C0025363 | |
| Disease | Mental deficiency | 8.71e-04 | 139 | 234 | 6 | C0917816 | |
| Disease | Neoplasm of the genitourinary tract | 8.81e-04 | 24 | 234 | 3 | cv:C0042065 | |
| Disease | Pleocytosis | 9.20e-04 | 6 | 234 | 2 | C0151857 | |
| Disease | Autoimmune lymphoproliferative syndrome | 9.20e-04 | 6 | 234 | 2 | cv:CN301239 | |
| Disease | Carcinoma in situ of uterine cervix | 9.20e-04 | 6 | 234 | 2 | C0851140 | |
| Disease | parenchymal hematoma, response to recombinant tissue-plasminogen activator | 9.20e-04 | 6 | 234 | 2 | EFO_0020101, EFO_0600080 | |
| Disease | Leukocytosis | 9.20e-04 | 6 | 234 | 2 | C0023518 | |
| Disease | paracentral lobule volume measurement | 9.95e-04 | 25 | 234 | 3 | EFO_0010317 | |
| Disease | Adenocarcinoma of large intestine | 1.02e-03 | 96 | 234 | 5 | C1319315 | |
| Disease | electrocardiography | SPTBN1 DBH PPARGC1A PTPN3 HRG PLEC WDPCP RNF207 PALLD PDZRN3 PLCE1 XPO7 | 1.16e-03 | 530 | 234 | 12 | EFO_0004327 |
| Disease | azoospermia (implicated_via_orthology) | 1.25e-03 | 27 | 234 | 3 | DOID:14227 (implicated_via_orthology) | |
| Disease | recalcitrant atopic dermatitis | 1.28e-03 | 7 | 234 | 2 | EFO_1000651 | |
| Disease | Thyroid cancer, follicular | 1.28e-03 | 7 | 234 | 2 | C2931367 | |
| Disease | smoking status measurement, Crohn's disease | 1.28e-03 | 7 | 234 | 2 | EFO_0000384, EFO_0006527 | |
| Disease | Wooly hair | 1.28e-03 | 7 | 234 | 2 | C0343073 | |
| Disease | Thymic Carcinoma | 1.28e-03 | 7 | 234 | 2 | C0205969 | |
| Disease | alkaline phosphatase measurement | ACACB SPTBN1 DHX38 DBH RRBP1 MYO3A ADSL DNAJC12 DMBT1 PDZRN4 RALGDS SLC4A8 DNAJB4 BTNL2 B3GAT1 LRBA EIF3J PLCE1 | 1.31e-03 | 1015 | 234 | 18 | EFO_0004533 |
| Disease | hypertrophic cardiomyopathy (implicated_via_orthology) | 1.54e-03 | 29 | 234 | 3 | DOID:11984 (implicated_via_orthology) | |
| Disease | prostate cancer (is_marker_for) | 1.58e-03 | 156 | 234 | 6 | DOID:10283 (is_marker_for) | |
| Disease | carcinoma (implicated_via_orthology) | 1.69e-03 | 64 | 234 | 4 | DOID:305 (implicated_via_orthology) | |
| Disease | Alzheimer's disease biomarker measurement, brain volume measurement | 1.70e-03 | 8 | 234 | 2 | EFO_0006514, EFO_0006930 | |
| Disease | binge eating | 1.70e-03 | 8 | 234 | 2 | EFO_0005924 | |
| Disease | colorectal cancer (implicated_via_orthology) | 1.71e-03 | 30 | 234 | 3 | DOID:9256 (implicated_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| YCADITSEEVRTLEE | 161 | O75528 | |
| NVRDIVYCTGVSLLD | 851 | Q9UKU6 | |
| CLYDRIAQETVDETE | 371 | Q7L4P6 | |
| LVDYITISRGCLTEQ | 96 | Q16537 | |
| YCTSDRDIVEVVRTE | 56 | Q9P2W7 | |
| QDCLFDRISESYVTL | 221 | Q96M60 | |
| CLRGEEETVTTLDYS | 16 | Q96RT1 | |
| LVDADCVVDSSQKRY | 231 | Q6ZUV0 | |
| DYREKVESELRSICT | 81 | P27348 | |
| VEELCQRVYSRGDSE | 206 | O75150 | |
| RSLTLRDDCQEYTTE | 2386 | A6H8Y1 | |
| QLLLCETLTETVYGD | 536 | Q9HCE6 | |
| NDACLVYDSRLVIDT | 951 | Q8NHU2 | |
| VATILYESRLGCLEN | 231 | Q4G0S4 | |
| SELIACEQDYVATLS | 1091 | Q8TER5 | |
| LDFLVTSYEEIIECA | 701 | Q8TC20 | |
| TSYEEIIECADQRLA | 706 | Q8TC20 | |
| EAYTREACIVEALGI | 546 | Q8NAG6 | |
| QVDRYIASEVCEDSI | 656 | Q9Y6K1 | |
| LCYIKTDITETTGRE | 386 | Q58F21 | |
| LVRVGEDIQLTCYLS | 256 | Q9UIR0 | |
| TSEDIRRELCDSYSG | 176 | Q86UK0 | |
| CQGLYTSDLEEDTRI | 216 | Q8NHS2 | |
| LDTCSRDTYALEQSL | 96 | Q14832 | |
| AISEGYCTEQLAEVR | 366 | Q7Z2Y8 | |
| VVNYSDSRTAEEICE | 236 | Q9BX10 | |
| ETNRTVYIAVCDDDL | 91 | Q8WXG9 | |
| TISCVVERTRGALDY | 1591 | Q8WXG9 | |
| RQVVSIYGSCLDVEL | 546 | O75843 | |
| AYVTDGACSEEDILR | 211 | O96020 | |
| DGIRTCDEYDSILAE | 56 | Q9Y5I7 | |
| YTLLGCDELSSVEQI | 16 | Q9UKB3 | |
| IYCDEIDLAADTVLA | 181 | Q9Y2F9 | |
| TVDLASRYECAAVVL | 196 | Q96GS6 | |
| SLYLLVDSVDEGCNI | 186 | Q9ULJ7 | |
| VTSLCYSEDGQEILV | 256 | Q58WW2 | |
| ETLCALAVDRYLAVT | 126 | P13945 | |
| TLTCYDSSDLELRLV | 251 | Q9NR16 | |
| LRLYSETETESCAGR | 1141 | Q9NR16 | |
| ETETESCAGRLEVFY | 1146 | Q9NR16 | |
| RLELVALVYSSCIAE | 301 | Q8IWY9 | |
| SLLEQDLATYITECS | 501 | O14578 | |
| RIERTVYCDETADES | 191 | Q96BY7 | |
| CELLTEDTTICYGED | 746 | O43520 | |
| EDTTICYGEDINSLL | 751 | O43520 | |
| ESCDSRAVLSERDLY | 126 | Q9ULX6 | |
| NYLSTETDIEDFRLC | 451 | Q8NE62 | |
| VYCLLDVSDITLEQD | 41 | Q6P387 | |
| VGDRYLLINSDIVCE | 131 | P25791 | |
| CLLDILDTAGQEEYS | 51 | P01112 | |
| CLLDILDTAGQEEYS | 51 | P01116 | |
| CLLDILDTAGQEEYS | 51 | P01111 | |
| LGLTVCYRTDDEDDI | 431 | Q9UPQ7 | |
| QEKLGLTVCYRTDDE | 411 | Q6ZMN7 | |
| LTVCYRTDDEEDTGI | 416 | Q6ZMN7 | |
| CNDKSYISEETRVLL | 1116 | Q29RF7 | |
| SANALILTYDITCEE | 81 | Q15771 | |
| SEAESCYINIARTLD | 201 | P26045 | |
| DLEIQCETLSEELTY | 206 | Q7Z3Y9 | |
| CYSRFSRESEDNILE | 971 | Q9UPP5 | |
| AYEEIVTISLVTCRA | 1921 | O00763 | |
| EILDLFSSVLYECVT | 1766 | Q9H1A4 | |
| ERIAYEVSVQECVSI | 351 | O75106 | |
| GQRCEVRLYDETESS | 191 | Q8N635 | |
| DELYEEVRLTLEGCS | 246 | O43586 | |
| SAICRVTLLDASEYE | 96 | Q9H4G0 | |
| ALIRLSCEDTSYNEI | 181 | O95918 | |
| VLEECEQRKYTSVSL | 391 | Q460N3 | |
| CRTDQELQYESLSEE | 206 | Q7Z3Y7 | |
| DTSEACARVIFITEY | 111 | Q9NSY0 | |
| VIEATEGEESLCYNR | 176 | Q96P67 | |
| LDVQESDCSVLSRKY | 71 | P04196 | |
| EEHLYILVCTRDSSA | 476 | Q96JG8 | |
| VTRDDDVLCVTEYSR | 206 | Q16787 | |
| TAIELGEETCTFRIY | 261 | P51116 | |
| STDLEFDRVVIYTTC | 131 | A8MXD5 | |
| YRCELINGIEDESVA | 126 | Q9GZV7 | |
| YLLREGEEFTVTCTI | 221 | P10721 | |
| QECILTETEARYTAL | 336 | Q6A163 | |
| CFRGEEEIISVLDYS | 16 | Q96NW7 | |
| LTDCQIYEVLSVIRD | 176 | Q16555 | |
| SVCSGRELYLEEALQ | 266 | Q9NTX5 | |
| YASFLEVLVRDVCIS | 176 | O75822 | |
| VIEISIYEDRCSSGS | 131 | Q2TAP0 | |
| LSGEYQRSSDCRILE | 491 | Q96KR4 | |
| DTLCDLYDTLTITQA | 266 | P38919 | |
| RDECLQSSEVILDYS | 61 | Q8N371 | |
| NCLLTSDLTVRIGDY | 271 | Q96Q04 | |
| EVRSVLADCVDIDSY | 181 | P50747 | |
| RGYCVSETELESVLT | 221 | Q8N187 | |
| IYLSEDALDCEIVSA | 421 | P40123 | |
| LVSCIDFRYITDVLT | 146 | Q7L5Y1 | |
| DTLCDLYETLTITQA | 261 | P60842 | |
| ESEYISAEQIVCEIG | 911 | Q9UIW2 | |
| EATVEYGVTSRCVTL | 346 | Q9ULL4 | |
| LEICALRDTVAVYLT | 856 | Q96KP1 | |
| TGTYIEDVARCVDQS | 456 | Q9NZN1 | |
| AGVCEELTYEEIRDT | 326 | Q16875 | |
| GSVLCLQYDERVIVT | 281 | Q9UKB1 | |
| TEVYNITLCTGDELT | 141 | Q9H706 | |
| EVDVDTRCSILNYLK | 546 | P48506 | |
| DEERARSCLTYLVSQ | 301 | Q14D04 | |
| LYRDTGVCILSSVDE | 846 | Q6ZR08 | |
| QCEVVRLTTETFYEV | 916 | O75164 | |
| ITLCRTDLEIQYETL | 196 | Q7Z3Z0 | |
| RQYLSDEIDLTICST | 486 | P50851 | |
| GEDQVTYSEARRLCT | 536 | Q9UBG0 | |
| SRVCRATDYLTDHEI | 271 | Q6ZNW5 | |
| ECEINTYRGLLESED | 391 | Q92764 | |
| RITRDDAAICTTEYS | 206 | O15230 | |
| SVETLLDVLVCLYTE | 26 | Q9Y5S2 | |
| EQSVALGEEVRRSYC | 581 | Q96MM6 | |
| DYRCVEVETDVVSNT | 31 | Q15024 | |
| RILDTCSRDTYALEQ | 101 | O00222 | |
| VTLETLVYEARCDVT | 886 | A2RRP1 | |
| LESCYLSEFQTIREE | 971 | O95613 | |
| ADNITYDIRKTCLDS | 756 | Q92832 | |
| ILQDLEDTDILSCSY | 71 | Q96JM4 | |
| RNLSVEAEVDLLSYC | 86 | Q9NUU6 | |
| TVLDGTEDYLILACD | 421 | Q8WY54 | |
| STDSDQCYLRETLEA | 426 | Q9UBK2 | |
| EVAEGSRVYLECRVT | 281 | Q8WX93 | |
| SICVEATESLGDYLR | 111 | Q8NHR9 | |
| ILSLDIESHRTCAYD | 2021 | O60494 | |
| ESIACDRDSGQLYVI | 286 | Q9ULW2 | |
| CEDSSLILYETHRRV | 356 | O95876 | |
| SLRCADDVAYINVET | 56 | Q9P0R6 | |
| IHELRVSLEEIYSGC | 161 | Q9UDY4 | |
| YLDVSAECTRRIVGV | 81 | Q9ULT8 | |
| DCVILDIENSSTYRI | 881 | Q4G0P3 | |
| LDTCSRDTYALEQAL | 96 | O15303 | |
| SRLSSVECLDYTADE | 341 | Q53G59 | |
| SSNRLEVSCETEVYE | 201 | Q53GT1 | |
| EGVTETVYNLIRSTC | 171 | P29017 | |
| TTDEILIRDTFRTYC | 61 | Q92947 | |
| LSEGCRAELAETIVY | 31 | Q9BQI4 | |
| DVQKEDALSTYRCIT | 186 | Q8TD84 | |
| ISDLRTEDSGTYICE | 281 | Q8TD84 | |
| LERSGTVIAYCNLEL | 81 | Q5SR53 | |
| EERCISDGVIYSIRT | 871 | Q8TF46 | |
| VLITSCTYNTEDREL | 461 | P09172 | |
| DTLVEEDTGTYECRA | 96 | P35613 | |
| ELYSQCFDELIREVT | 126 | O14645 | |
| EAEQLRAYLDGTCVE | 176 | P04439 | |
| ATDDITELYSTLECL | 201 | O00458 | |
| TELYSTLECLENIFT | 206 | O00458 | |
| ESKEEYARSTRGCLE | 631 | Q8TF61 | |
| ERLSETESYNLSCEL | 631 | Q12967 | |
| YVVRCRDEDSKQVSE | 481 | P42701 | |
| SDYVGTCERLIELVD | 206 | Q68D91 | |
| AECTAEEAYTLTEGR | 426 | P23368 | |
| CIIGTEEAYDIINRE | 161 | P49356 | |
| VEYAALTDDDCSVTV | 746 | Q9ULK0 | |
| LDTCSRDTYALEQSL | 106 | Q14831 | |
| LAEERLVTEKASVYC | 516 | Q76NI1 | |
| DSVDYIQVCDSDTVL | 206 | O00219 | |
| AYVVTRTVSCVLEDG | 61 | Q9Y6C2 | |
| RTVSCVLEDGVETYV | 66 | Q9Y6C2 | |
| CLRNFVESLYDTTLE | 336 | Q5TBA9 | |
| YTSITRARFEELCSD | 296 | P17066 | |
| NYTCEVTELTREGET | 111 | Q08722 | |
| LSESCSIESDIYAEI | 391 | Q14289 | |
| IVLDDVRCSGNESYL | 556 | Q9UGM3 | |
| SCEVFEILLSRGYSE | 2821 | Q8IVF4 | |
| RRAVDEIYVTCESDQ | 111 | Q9BY12 | |
| DRLEASSGILEVLYC | 551 | P21817 | |
| CDAISAVEEKVSYLR | 371 | Q96EK5 | |
| LVTCADDIELYSIGE | 176 | O14772 | |
| TGQEEIDTACEILYE | 781 | Q14562 | |
| ETLCSLQEADYEVAS | 151 | Q96EK7 | |
| ILDSYQCTAEISLAD | 31 | P02771 | |
| EECESYTVRDLLVTN | 666 | P18433 | |
| CEELEYSSLLDQASR | 511 | Q9BZF2 | |
| DTVELATYCVRTFAL | 1486 | P23468 | |
| RRSSLSYEDADCVVI | 1041 | P22897 | |
| TGSLSELQISYVCRE | 106 | Q92918 | |
| YDSLSEIDILSAVLC | 1226 | Q8NET4 | |
| CGETYEDFDTRILEV | 211 | P82675 | |
| YECEESFTTLNVDIR | 1731 | Q93008 | |
| VDLESAYVQGCERLE | 191 | Q6ZRF8 | |
| TDAYLECIERITFSG | 936 | Q92673 | |
| DASSLVCYITRFTEE | 711 | Q9Y6M7 | |
| VAEVLSECRLLAYIS | 646 | Q8TEL6 | |
| YEDLVSCVTRAEAEA | 296 | P04053 | |
| LECEINTYRSLLESE | 391 | O76011 | |
| TERCESALQSLEGRY | 826 | Q8N4C6 | |
| YNSVAEEDLCLETGI | 126 | Q9P212 | |
| QSSLYEARDVEVARC | 596 | Q5T2S8 | |
| ISVCGDVYTLRETRS | 211 | Q9HAT8 | |
| TSCYVGDNTDLIILR | 111 | P30566 | |
| TLISREDVEALYTSC | 81 | Q1XH10 | |
| EDVEALYTSCKTERV | 86 | Q1XH10 | |
| CDSAIEYLLDQTDVL | 191 | Q9H0W8 | |
| TIEDSYTKQCVIDDR | 46 | P62070 | |
| LLCTAYVFEVSTSER | 421 | Q15562 | |
| YGIRLVDSESLSCIT | 246 | Q8IZU2 | |
| YLCELLEEVAEGVAS | 241 | O95785 | |
| NEELCEYVKSRLEVS | 251 | O75688 | |
| DASSLVCYITRFTEE | 581 | Q2Y0W8 | |
| IRTLADSVCRYDLND | 131 | Q6IE81 | |
| ERCIEYIEATGLSTE | 1266 | Q9NRY4 | |
| DQCRYIRDIATETVG | 331 | Q01968 | |
| EIDLRSCTDVTEYAV | 1836 | Q9H2D6 | |
| TLEELCDTEYFTQTL | 321 | Q8TEV9 | |
| VSCRITDLYTDLRDG | 71 | Q01082 | |
| SLIELELSYCIEIGE | 1791 | Q8N3C0 | |
| ELSYCIEIGEDNRSI | 1796 | Q8N3C0 | |
| DTVSLQCTYREELRD | 31 | Q6UXG3 | |
| ILFSRCSGTIYAEEE | 56 | Q6UXG3 | |
| EDCRSTDEIRQSDYI | 246 | Q86WS4 | |
| YAVRDTIALCTAESI | 191 | Q8NB49 | |
| YVCSLTEDLVTKARE | 31 | Q9BTX7 | |
| YTVKLERLESCDTVG | 71 | Q9H7R5 | |
| ALDLLCSAIRESYSE | 586 | Q96JI7 | |
| SEVLIDLTEYCGQLV | 171 | Q8N5D0 | |
| EDNSDEKIRIYTCVL | 811 | Q7Z3J2 | |
| QYEASCVSFERVLVE | 41 | Q8N2C7 | |
| ETISTDVCNRKDVYD | 351 | Q6ZWK6 | |
| AECDQYRSILAETEG | 1126 | Q9P2E9 | |
| VDETIFLLESYIECT | 516 | Q9BUI4 | |
| CSETTLVNIYDLSDE | 111 | Q4G0A6 | |
| AELLLDIESVITFYC | 101 | Q9NUY8 | |
| YLTSECENVALVLER | 91 | O60281 | |
| VRVSLYDLASVDSCE | 336 | Q9Y5S1 | |
| NCDSLRESDTIVYLL | 891 | Q3MJ13 | |
| ECYREASLSILEQLS | 581 | Q6ZS81 | |
| YAIRFEDCTSENTLI | 611 | Q92620 | |
| LVSGLLNELYSCTEE | 81 | Q9Y2I9 | |
| SECAIDRLRSDYTTL | 2036 | Q86WI1 | |
| YSCDRSATVTRLEDL | 886 | Q15149 | |
| LQHELRTLTVEGCEY | 946 | Q14997 | |
| SENLSLTTCEYRREG | 1366 | Q4KWH8 | |
| YEQILGITCVESSLR | 316 | P85298 | |
| LTVTCSSYDDRVVLG | 556 | Q9C026 | |
| DVTRFLQDSVEYCII | 136 | Q9UIA9 | |
| QDELESIERSYACSV | 96 | P17031 | |
| REIEYTVICETSLQA | 956 | Q5TAH2 | |
| ETVELGSYEKCQDLR | 61 | Q8TD55 | |
| SCDTDAEILYELLTQ | 121 | Q7Z2W7 | |
| SRAFCETLEETNYRL | 226 | P57768 | |
| CAYTIQSIERILSDE | 1336 | Q8IWV8 | |
| YLCQTDTEAVREAAR | 1171 | Q6ZS17 | |
| QRLILSDDCTIVAYG | 306 | Q9BVG3 | |
| CTELGIRTVAIYSEQ | 56 | P11498 | |
| VRVCEATYDTTLVEK | 46 | Q93096 | |
| TCGEEASVLEILVYN | 426 | Q9HBA0 | |
| QRRLVESTEVECYDS | 126 | Q8N6N2 | |
| GDFISTQYILDCVER | 76 | Q9NYB0 | |
| ENTVSEQLEKCYSRD | 351 | Q8NEV4 | |
| YAELRDTINTSCDIE | 1091 | Q9UM54 | |
| AYDLTFCEVRDTSLV | 816 | P54296 | |
| EIRRCAIEDSATYTV | 216 | Q5VTT5 | |
| KQLEDTTAYCGERVE | 346 | Q00872 | |
| TTAYCGERVELECEV | 351 | Q00872 | |
| ELSELVYTDVLDRSC | 81 | Q8WU39 |